Methods for making releasable polymeric reagents
The improved method for preparing fluorenyl-based polymeric reagents using anhydrous conditions and di-BTC stabilizes the reagents, reducing impurities and enhancing stability, leading to higher yields and effective biologically active conjugates.
Patent Information
- Application Number
- JP2021518960
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2018-10-11
- Filing Date
- 2019-10-11
- Publication Date
- 2024-11-01
- Estimated Expiration
- 2039-10-11
AI Technical Summary
Existing methods for preparing fluorenyl-based polymeric reagents, such as PEGylated FMOC reagents, suffer from undesirable side reactions and impurities, leading to reduced efficacy and stability of the final conjugates due to the formation of polymeric fulvene by-products.
An improved method involving the use of anhydrous conditions and specific solvents, along with the use of dibenzotriazolyl carbonate (di-BTC) and acidic additives, to minimize side reactions and stabilize the polymeric reagents, including the conversion to N-hydroxysuccinimidyl carbonate esters, thereby reducing impurities and enhancing stability.
The method results in higher yields and improved stability of the polymeric reagents, minimizing the formation of fulvene impurities and ensuring greater efficacy in forming biologically active conjugates.
Smart Images

Figure 0007577055000001 
Figure 0007577055000002 
Figure 0007577055000003
Abstract
Description
[Technical field]
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims the benefit of priority under 35 U.S.C. §119(e) to U.S. Provisional Application No. 62 / 744,512, filed October 11, 2018, the disclosure of which is incorporated herein by reference in its entirety.
[0002] This application relates (among other things) to improved methods for preparing fluorenyl-based polymeric reagents, methods for recovering and purifying such polymeric reagents, methods for reducing undesirable impurities in fluorenyl-based polymeric reagents, fluorenyl-based polymeric reagents prepared by the methods described herein, and conjugates prepared by reaction with fluorenyl-based polymeric reagents prepared by the methods described herein. [Background technology]
[0003] Modification of bioactive molecules with covalent attachment of polyethylene glycol can enhance the pharmacological and pharmaceutical properties of such molecules and has been used successfully in several approved drugs. For example, PEGylation has been used to create marketed drugs in which a biological agent is covalently attached to polyethylene glycol by a stable bond, such as CIMZIA® (PEGylated tumor necrosis factor (TNF)), NEULASTA® (PEGylated granulocyte colony stimulating factor (GCSF)), PEGASYS® (PEGylated interferon alpha-2a), and ADYNOVATE® (PEGylated factor VIII). In many cases, the stable covalent attachment of one or more polyethylene glycol chains to an active agent results in a PEG conjugate that has reduced functional activity when compared to the unmodified molecule. When an active drug is covalently attached to a polymer via a stable linkage, the drug attached to the polymer may retain the properties of the unattached drug, but its efficacy per gram of drug will generally differ from that of the unmodified drug, since the covalently attached polymer may, among other things, change the steric and electronic environment surrounding the drug molecule, making the drug less effective (per gram of drug). However, this effect can in some cases be offset, for example, by a longer circulation time to achieve enhanced efficacy of the drug.
[0004] There are also PEGylation techniques in which PEG reagents are covalently attached to therapeutic agents via releasable linkages. Releasable PEGylation (sometimes referred to as "reversible PEGylation") is a technique in which an active agent conjugate (comprising a drug molecule releasably chemically linked to one or more water-soluble polymeric moieties, such as polyethylene glycol, etc.) releases one or more polymeric moieties from the drug over time through chemical processes occurring in vivo after administration. Such releasable polymer-modified drugs are sometimes referred to as prodrugs, since theoretically the polymer can be released into the blood circulation over a long period of time and regain the activity of the parent drug molecule. The effectiveness of a releasable drug delivery system can be influenced, for example, by the release rate of one or more covalently attached polymeric moieties from the drug conjugate. One type of PEGylation reagent that may be used to form drug conjugates capable of undergoing reversible (releasable) PEGylation is based on the fluorenylmethyloxycarbonyl (FMOC) amine protecting group (see, e.g., Wuts, PG, Greene, TW, Protective Groups in Organic Synthesis, Fourth Ed., 2007, John Wiley & Sons, Inc., New Jersey; Bentley, MD, et al., U.S. Pat. No. 8,252,275; Shechter Y., et al., Eur J Pharm Biopharm, 2008, 70, 19-28). A generalized structure of one particular species of these reagents, referred to herein as polymeric reagents or in certain instances PEGylated FMOC reagents, having branched structures, is shown below in Structure X (see, e.g., Bentley, MD, et al., U.S. Pat. No. 8,252,275, which is incorporated herein by reference in its entirety, where L1 and L2 and R e1 and R e2 (An explanation is provided for the structure shown.) In this illustrative structure, the polymeric reagent is activated as an N-hydroxylsuccinimidyl carbonate (NHS) ester, i.e., it contains a succinimidyl carbonate leaving group. [ka] The PEG2 FMOC reagents may be reacted with therapeutic agents that contain a nucleophilic atom that can react with an FMOC-type reagent to form, for example, a carbamate adduct. This reaction scheme is illustrated below, showing, as an example, the reaction of a protein lysine group with a generalized form of a typical PEG2-FMOC reagent that contains a reactive N-succinimidyl carbonate group (Scheme I). [ka] [Prior art documents] [Patent documents]
[0005] [Patent Document 1] U.S. Patent No. 8,252,275 [Non-patent literature]
[0006] [Non-Patent Document 1] Wuts, P.G., Greene, T.W., Protective Groups in Organic Synthesis, Fourth Ed., 2007, John Wiley & Sons, Inc., New Jersey. [Non-Patent Document 2] Shechter Y., et al., Eur J Pharm Biopharm, 2008, 70, 19-28 Summary of the Invention [Problem to be solved by the invention]
[0007] During the preparation of various FMOC reagents by the previously described synthetic approaches, applicants have experienced undesirable side reactions. These side reactions can result in the formation of undesirable by-products that (i) in some cases can adversely affect the quality of the final polymer-therapeutic agent conjugate and (ii) can alter the mechanism of release of the FMOC polymer component from the therapeutic agent. The present disclosure describes problems associated with previously described methods of preparing the subject polymeric FMOC reagents and provides several process improvements aimed at solving such problems, thereby providing, for example, improved methods for making polymeric FMOC reagents, improved methods for making intermediates useful for preparing polymeric FMOC reagents, improved methods for activating FMOC intermediates, methods for removing one or more undesirable polymeric FMOC-derived by-products or impurities, and methods for stabilizing certain polymeric FMOC reagents, among others. The present disclosure therefore seeks to address these and other problems related to the preparation of the subject polymeric FMOC reagents and their conjugates. [Means for solving the problem]
[0008] In a first aspect, provided herein is a method, i.e. an improved method, for preparing a reactive polymeric reagent, comprising: (i) reacting a water-soluble 9-hydroxymethylfluorene polymer having the structure (I): [ka] Here, POLY a is a first water-soluble, non-peptidic polymer; POLY b is a second water-soluble, non-peptidic polymer; R e1 is, if present, a first electron changing group; and R e2 is a second electron changing group, if present; L1 is a first linking moiety; and L2 is a second linking moiety; with dibenzotriazolyl carbonate (BTC) in an aprotic organic solvent in the presence of a base under anhydrous conditions to provide a reaction mixture comprising a water soluble 9-methylbenzotriazolyl carbonate fluorene polymer having the structure: [ka] Here, POLY a , POLY b , R e1 , R e2 , L1, and L2 each have the meaning described in step (i) and (ii) recovering the water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer (II) by precipitation with an anhydrous solvent effective to promote precipitation of the water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer.
[0009] In one or more embodiments related to this method, in step (i), the water-soluble 9-hydroxymethylfluorene polymer of structure (I) is reacted with less than about 30 equivalents of dibenzotriazolyl carbonate (di-BTC).
[0010] In some embodiments, the base is an amine. In some further embodiments, the base is a non-nucleophilic amine or a slightly nucleophilic amine. Bases include, for example, pyridine, 4-dimethylaminopyridine, N,N-diisopropylethylamine, 2,6-di-tert-butylpyridine, N-methylimidazole, N-methylmorpholine, 2,6-lutidine, 2,4,6-collidine, N,N,2,6-tetramethylpyridin-4-amine, and insoluble polymer-bound forms of any of the foregoing. The amine may also be a polyamine, such as, for example, N,N,N',N'-tetramethyl-1,6-hexamethyldiamine, N,N',N',N",N"-pentamethyldiethylenetriamine, and hexamethylenetetramine.
[0011] In one or more embodiments of this method, in step (ii), the anhydrous solvent effective to promote precipitation further comprises an acid.
[0012] In yet some further embodiments, the method further comprises, prior to the reacting step, dissolving the water-soluble 9-hydroxymethylfluorene polymer of structure (I) in an aprotic organic solvent to form a polymer solution and drying the polymer solution by azeotropic distillation to provide a polymer solution having a water content of less than about 500 ppm.
[0013] In some other embodiments, the recovered water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer of step (ii) comprises less than 10 mole percent water-soluble fulvene polymer.
[0014] In yet some other embodiments of the method, the recovering step comprises filtering the reaction mixture of step (i) to remove solids to provide a solution comprising the water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer, followed by adding an effective amount of anhydrous solvent to precipitate the water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer from the solution.
[0015] In yet some other embodiments, anhydrous solvents effective to promote precipitation of the water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer contain small amounts of acid.
[0016] Additionally, in some further embodiments, the method includes washing the recovered water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer with an anhydrous solvent in which the water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer is insoluble or substantially insoluble, the solvent comprising from about 0.0001 to about 0.5 mole percent acid.
[0017] In some further embodiments, the method further comprises (iii) purifying the recovered water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer.
[0018] In a second aspect, provided herein is a method comprising converting the recovered or purified water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer described above to a different reactive carbonate, such as, for example, a water-soluble 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymer, under conditions effective to effect such conversion. In one or more illustrative embodiments, such conversion is carried out in the presence of dimethylaminopyridine. In one or more embodiments, the conversion reaction is further carried out in a solvent, such as, for example, dichloromethane.
[0019] In a third aspect, there is further provided a method for preparing an N-hydroxylsuccinimidyl carbonate ester activated polymeric reagent, the method comprising: (i) reacting a water-soluble 9-hydroxymethylfluorene polymer having the following structure: [ka] Here, POLY a is a first water-soluble, non-peptidic polymer; POLY b is a second water-soluble, non-peptidic polymer; R e1 is the first electron changing group, if present; R e2 is a second electron transfer group, if present; L1 is a first linking moiety; L2 is a second linking moiety; R e1 is a first electron changing group, which may or may not be present; and R e2 is a second electron changing group, which may or may not be present; with about 1-20 equivalents of disuccinimidyl carbonate in an anhydrous aprotic organic solvent in the presence of a base to provide a reaction mixture comprising a water soluble 9-methyl N-succinimidyl carbonate fluorene polymer having the following structure: [ka] Here, POLY a , POLY b , R e1 , R e2 , L1, and L2 each have the meaning described in step (i); and (ii) recovering the water-soluble 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymer of structure (III) from the reaction mixture.
[0020] Exemplary water-soluble 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymers include the following structures XI-XIV, where mPEGO~ is methoxypolyethylene glycol or CHO(CHCHO) n is an abbreviation for CH2CHO- (as would be expected, any of a number of reactive groups suitable for reacting with functional groups of a targeting drug molecule, such as benzotriazolyl carbonate, as well as other water-soluble polymer chains substituted on the fluorene core other than polyethylene glycol, can also be envisioned), each (n) ranging from about 3 to 2273, including each and every subrange and specific value for (n) described elsewhere herein; [ka] Structure (XI): 9-Hydroxymethyl-4-(mPEG-carboxamido)-7-(3-(mPEG carbamoyl-propyl)-fluorene-N-hydroxysuccinimidyl carbonate ("CAC-PEG2-FMOC-NHS") [ka] Structure (XII): 9-hydroxymethyl-2,7-di(mPEG-amidoglutaramido)fluorene-N-hydroxysuccinimidyl carbonate ("G2-PEG2-FMOC-NHS") [ka] Structure (XIII): 9-hydroxymethyl-4-(mPEG-carboxyamido)-7-(mPEGamidoglutaramido)fluorene-N-hydroxysuccinimidyl carbonate ("CG-PEG2-FMOC-NHS") and [ka] Structure XIV: 9-hydroxymethyl-2,7-(bis-mPEG-carboxamido)-fluorene-N-hydroxysuccinimidyl carbonate ("C2-PEG2-FMOC-NHS").
[0021] In some embodiments of the aforementioned method, prior to the reacting step (i), the water-soluble 9-hydroxymethylfluorene polymer is dissolved in an anhydrous aprotic organic solvent to provide a polymer solution, which is subsequently dried to remove any water present to provide a dry polymer solution having a water content of less than 500 ppm.
[0022] In some further embodiments of the method, the drying is repeated until a dry polymer solution having a water content of less than 200 ppm is reached.
[0023] In some other particular embodiments, the drying step comprises azeotropically distilling the polymer solution.
[0024] In some further embodiments related to the foregoing, the drying is repeated until the water content of the polymer solution remains constant.
[0025] In one or more other embodiments, the method further comprises, prior to the recovering step, adding an acid to the reaction mixture of step (i) in an amount effective to neutralize the base.
[0026] In some embodiments, the methods are effective to produce recovered water-soluble 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymers that contain 15 mole percent or less of the water-soluble fulvene polymer.
[0027] In one or more embodiments of the method, the precipitating solvent is at a temperature above its freezing point and below room temperature.
[0028] In still some further embodiments, the precipitating solvent comprises a small amount of acid.
[0029] In some embodiments, the method further comprises washing the recovered water-soluble 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymer with an acidified precipitating solvent.
[0030] In one or more embodiments, the method further comprises purifying the recovered water-soluble 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymer.
[0031] In yet some other embodiments, the purification step includes dissolving the recovered water-soluble 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymer in a solvent to provide a solution, passing the solution through a thiol-containing resin to remove any water-soluble fulvene polymer, thereby providing a purified solution, and removing the solvent from the purified solution to recover the purified water-soluble 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymer.
[0032] In yet one or more further embodiments, the recovered or purified water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer or other reactive carbonate prepared by the methods described herein is reacted with an amine-containing biologically active agent to provide a conjugate.
[0033] In another aspect, a brominated water-soluble fluorene polymer is provided. In one or more embodiments, the brominated water-soluble fluorene polymer has a structure selected from the following: [ka] Here, POLY a , POLY b , L1, and L2 have the meanings described elsewhere herein.
[0034] Other aspects and embodiments are set forth in the following description and claims. BRIEF DESCRIPTION OF THE DRAWINGS
[0035] This paragraph was intentionally left blank as a placeholder. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0036] definition In describing and claiming certain features of the present disclosure, the following terminology will be used in accordance with the definitions set out below unless otherwise stated.
[0037] As used herein, the singular forms "a," "an," and "the" include plural referents unless the context clearly indicates otherwise. Thus, for example, reference to a "polymer" includes a single polymer as well as two or more of the same or different polymers, reference to a "conjugate" is a reference to a single conjugate as well as two or more of the same or different conjugates, reference to an "excipient" includes a single excipient as well as two or more of the same or different excipients, etc.
[0038] "Water-soluble non-peptidic polymer" refers to a polymer that is at least 35% (by weight) soluble in water at room temperature. However, preferred water-soluble non-peptidic polymers are preferably more than 70% (by weight), more preferably more than 95% (by weight) soluble in water. Usually, an unfiltered water-soluble preparation of a "water-soluble" polymer transmits at least 75% of the amount of light that the same solution transmits after filtering. Preferably, such an unfiltered water-soluble preparation transmits at least 95% of the amount of light that the same solution transmits after filtering. Most preferred are water-soluble polymers that are at least 95% (by weight) soluble in water or completely soluble in water. With respect to "non-peptidic", a polymer is non-peptidic if it contains less than 35% (by weight) amino acid residues.
[0039] The terms "monomer", "monomer subunit" and "monomer unit" are used interchangeably herein and refer to one of the basic structural units of a polymer. In the case of a homopolymer, a single repeating structural unit forms the polymer. In the case of a copolymer, two or more structural units repeat in a pattern or randomly to form the polymer. The preferred polymers used in connection with the present invention are homopolymers. Water-soluble, non-peptidic polymers contain three or more monomers added sequentially to form a chain of monomers.
[0040] As used herein, "PEG" or "polyethylene glycol" is intended to encompass any water-soluble poly(ethylene oxide). Unless otherwise specified, a "PEG polymer" or polyethylene glycol is one in which substantially all (preferably all) monomer subunits are ethylene oxide subunits, although the polymer may contain unique end-capping moieties or functional groups, e.g., for conjugation. PEG polymers generally include one of the two following structures, depending on whether the terminal oxygen has been replaced, e.g., during synthetic transformations: "-(CH2CHO) n -" or "-(CH2CH2O) n-1CH2CH2-". As noted above, for PEG polymers, the variable (n) ranges from about 3 to 2273, and the end groups and overall PEG configuration can vary. Other subranges for "n" are described herein. PEG polymers related to this disclosure are typically end-capped, with the preferred end-capping group being a lower alkyl group, and the most preferred end-capping group being methyl.
[0041] Molecular weights for water-soluble polymers such as PEG can be expressed as number average molecular weight or weight average molecular weight. Unless otherwise specified, all references to molecular weight herein refer to weight average molecular weight. Both molecular weight measurements, number average and weight average, can be measured using gel permeation chromatography or other liquid chromatography techniques (e.g., gel filtration chromatography). The most commonly used are gel permeation chromatography and gel filtration chromatography. Other methods for determining molecular weight include the use of end group analysis or colligative measurements (e.g., freezing point depression, boiling point elevation, or osmotic pressure) to determine number average molecular weight, or light scattering techniques, ultracentrifugation, MALDI TOF, or viscometry to determine weight average molecular weight. PEG polymers are typically polydisperse (i.e., the number average molecular weight and the weight average molecular weight of the polymer are not equal) and have a low polydispersity value, preferably less than about 1.2, more preferably less than about 1.15, even more preferably less than about 1.10, even more preferably less than about 1.05, and most preferably less than about 1.03.
[0042] "Branched," in reference to the geometry or overall structure of a polymer, refers to a polymer having two or more polymer "arms" or "chains" extending from a branch point or central structural feature. Some preferred examples of branched polymers are those that have one or more of the following characteristics: having two or more polymer arms, having two polymer arms, being composed of polymer chains having the same structure (e.g., composed of the same monomer subunits), and being composed of polymer arms having the same weight average molecular weight.
[0043] A "stable" linkage or bond refers to a chemical bond that is substantially stable in water, i.e., does not undergo hydrolysis or degradation under physiological conditions to any appreciable extent over an extended period of time. Examples of hydrolytically stable linkages generally include, but are not limited to, the following: carbon-carbon bonds (e.g., in aliphatic chains), ether bonds, amide bonds, amine bonds, and the like. However, as will be appreciated by those skilled in the chemical arts, it should be understood that the stability of any particular chemical bond can be influenced by the particular structural features of the molecule in which the bond is placed, as well as the placement of the subject linkage within a particular molecule, adjacent and neighboring atoms, and the like. One of skill in the art can determine whether a particular linkage is stable or releasable in a particular situation, for example, by placing the linkage-containing molecule of interest under the conditions of interest (e.g., under physiological conditions) and testing for evidence of release over a suitable period of time. Generally, a stable linkage is one that exhibits a rate of hydrolysis of less than about 1-2% per day under physiological conditions. Hydrolysis rates for representative chemical bonds can be found in standard organic chemistry textbooks.
[0044] For example, a covalent "releasable" linkage with respect to a water-soluble polymer, such as a polymeric FMOC reagent, that is covalently attached to a target molecule, such as an active ingredient or other molecule, is a linkage that, under physiological conditions, releases or detaches one or more water-soluble polymers from the active ingredient. Release may occur, for example, by any suitable mechanism and at a clinically useful rate. A releasable linkage may also be referred to as a physiologically cleavable bond or linkage.
[0045] "Alkyl" refers to a hydrocarbon chain, typically ranging from about 1 to 15 atoms in length. Such hydrocarbon chains are preferably, but not necessarily, saturated and may be branched or straight-chained, although straight-chained is usually preferred. Typical alkyl groups include methyl, ethyl, propyl, butyl, pentyl, 3-methylpentyl, and the like.
[0046] "Lower alkyl" refers to an alkyl group containing from 1 to 6 carbon atoms and may be straight chained or branched, as exemplified by methyl, ethyl, n-butyl, i-butyl, and t-butyl.
[0047] "Alkoxy" refers to the group -OR, where R is alkyl or substituted alkyl, preferably C 1~6 and alkyl (eg, methoxy, ethoxy, propyloxy, etc.).
[0048] The term "substituted", as in "substituted alkyl", includes, but is not limited to, alkyl, C 3~8It refers to a moiety (e.g., an alkyl group) that is substituted with one or more non-interfering substituents, such as cycloalkyl, e.g., cyclopropyl, cyclobutyl, and the like; halo, e.g., fluoro, chloro, bromo, and iodo; cyano; alkoxy, lower phenyl; substituted phenyl; and the like. "Substituted aryl" is an aryl that has one or more non-interfering groups as a substituent. For substitutions on a phenyl ring, the substituents may be in any orientation (i.e., ortho, meta, or para). Substituents on an aryl moiety that is part of a more complex system, such as a naphthalene or fluorene core, may occupy any position on the aryl ring that is not otherwise occupied in that structure.
[0049] "Non-interfering substituents" are those groups that, when present in a molecule, are typically non-reactive with other functional groups contained within the molecule.
[0050] "Aryl" means one or more aromatic rings, each of 5 or 6 core carbon atoms. Aryl includes multiple aryl rings that may be fused, as in naphthyl, or unfused, as in biphenyl. Aryl rings may also be fused or unfused with one or more cyclic hydrocarbon, heteroaryl, or heterocyclic rings. As used herein, "aryl" includes heteroaryl. Aromatic moieties (e.g., Ar 1 , Ar 2 etc.) refer to structures containing aryl.
[0051] "Heteroaryl" is an aryl group containing one to four heteroatoms, preferably sulfur, oxygen, or nitrogen, or a combination thereof. Heteroaryl rings may also be fused to one or more cyclic hydrocarbon, heterocyclic, aryl, or heteroaryl rings.
[0052] "Heterocycle" or "heterocyclic ring" means one or more rings of 5 to 12 atoms, preferably 5 to 7 atoms, with or without unsaturation or aromatic character and having at least one ring atom that is not carbon. Preferred heteroatoms include sulfur, oxygen, and nitrogen.
[0053] A "substituted heteroaryl" is a heteroaryl having one or more non-interfering groups as substituents.
[0054] A "substituted heterocycle" is a heterocycle having one or more side chains formed from non-interfering substituents.
[0055] As used herein, "organic radical" is intended to include alkyl, substituted alkyl, aryl, and substituted aryl.
[0056] An "anhydrous" material is one that contains 500 parts per million (ppm) water or less. Preferably, the anhydrous material or condition is one that contains 450 ppm water or less, or 400 ppm water or less. More preferably, the anhydrous material or condition contains 200 ppm water or less. Most preferably, the anhydrous material contains less water than is measurable by modern analytical methods, which is currently less than 100 ppm. An illustrative range of water content for the anhydrous materials or conditions described herein is from about 80 ppm to about 200 ppm.
[0057] For example, "anhydrous conditions" with respect to reaction conditions refers to conditions in which care has been taken to remove moisture from reactants, solvents, glassware, atmosphere, and the like. Anhydrous conditions typically include the use of dry solvents (using any suitable drying technique familiar to those skilled in the chemical arts), dry reagents, an inert atmosphere, dry reaction equipment, and the like. Conventional methods for drying solvents and measuring residual moisture in such solvents may be found in works such as those by Pangborn, AB, et al Organometallics, 1996, 15, 1518-1520; and Williams, DBG, et al J. Org. Chem. 2010, 75, 8351-8354.
[0058] "Substantially" or "essentially" means almost entirely or completely, for example, 95% or more of a particular quantity.
[0059] Similarly, as used herein, "about" or "approximately" means within plus or minus 5% of a particular quantity.
[0060] "Optional" or "optionally" means that the subsequently described circumstance does not necessarily have to occur, but may occur, and the description will encompass cases where the circumstance occurs and cases where it does not occur.
[0061] A "pharmaceutically acceptable excipient" or "pharmaceutically acceptable carrier" refers to a component that may be included in the compositions described herein and that causes no significant adverse toxicological effects in a subject.
[0062] The term "patient" or "subject" as used herein refers to an organism suffering from or prone to a condition that can be prevented or treated by administration of a compound or composition or combination provided herein, such as cancer, and includes both humans and animals. Subjects include, but are not limited to, mammals (e.g., murines, apes, equines, bovines, porcines, canines, felines, and the like), and are preferably humans.
[0063] overview Polymeric FMOC reagents and some of the intermediates that lead to the final polymeric reagents are susceptible to base-catalyzed loss of carbonate functionality. The basic moieties of the material that catalyze the decomposition of the reagents may be negatively charged or uncharged. This process is the same type of process that provides efficacy to PEG2-FMOC-therapeutic agent conjugates (note that references to PEG-containing reagents or conjugates herein are also intended to apply equally to other water-soluble polymers such as those described herein). More specifically, PEG2-FMOC conjugates release the covalently attached therapeutic agent ("drug") by reaction in vivo with any material that can split off the ionizable benzylic proton at the 9-position of the fluorene ring. The drug release process is illustrated in Scheme II for a particular illustrative PEG2-FMOC conjugate structure. [ka]
[0064] Following a similar mechanistic route as that illustrated in Scheme II, the PEG2-FMOC-NHS reagent (or any other suitably activated PEG2-FMOC reagent) can be reacted with a charged or uncharged basic substance. This is shown in Scheme III, which illustrates the mechanism by which an unfavorable base-catalyzed elimination reaction of the PEG2-FMOC intermediate or reagent leads to a PEG2 fulvene derivative. [ka]
[0065] The PEG2-FMOC-BTC intermediate is decomposed following a similar base-catalyzed process as shown for the NHS reagent in Scheme III, with the leaving group being 1-hydroxybenzotriazolyl rather than N-hydroxysuccinimide.
[0066] Thus, to provide convenient polymeric reagents, the synthetic processes leading to these and other similar ester-like reagents should ideally be carried out under conditions effective to minimize losses due to basic interactions with intermediates and final reagents. Such an approach is useful when the fluorene ring is substituted with R in structure X. e1 and R e2 It is particularly preferred when the linker connecting the polymer, i.e., L1 or L2, is substituted with one or more electron-withdrawing groups such as. For example, when the linker connecting the polymer, i.e., L1 or L2, becomes more electron-withdrawing due to the presence of an atom adjacent to or directly attached to the fluorene core, the reaction methods, conditions, intermediates, product recovery, and purification procedures described herein illustrate that handling and care, for example, to remove basic substances during processing or work-up steps, can also be important. For example, the presence of an electron-withdrawing group attached to the fluorenyl core can make the elimination reaction much easier, since the electron-withdrawing effect can affect the proton at position 9, making it more acidic and therefore more susceptible to removal by basic species (e.g., Schemes II and III). Therefore, base-catalyzed decomposition can be particularly problematic, and while it is usually not critical for PEG2-G2-FMOC reagent species, it can be very significant for PEG2-C2-FMOC reagents and reactive intermediates. As a result, it has been discovered that processes previously described for the production of less reactive PEG-FMOC reagents are less favorable for yielding quality, highly reactive PEG-FMOC reagents (such as NHS reagents) and may not be successfully applied to the preparation of all reactive types of PEG-FMOC reagents.
[0067] One consequence of the presence of PEG2fulvene in the reagent is the potential for undesirable side reactions to occur between the targeted therapeutic agent and the PEG2fulvene impurity, as shown in the illustrative Scheme IV below (the exemplary water-soluble FMOC reagent shown is intended to be illustrative and not limiting with respect to the structure of the FMOC polymeric fulvene). [ka]
[0068] In this reaction, a thiol group of a therapeutic agent, such as a protein, can react with PEG2 fulvene (see, for example, Culbertson, S., et al., U.S. Pat. No. 8,905,235). Upon formation of the polymer conjugate shown in Scheme IV, rather than the intended conjugate formed by reaction between a PEG2 FMOC activated carbonate reagent and, for example, a protein (see, for example, Scheme I), the release of the protein can occur by an entirely different mechanism and under very different environmental conditions. Thus, in one or more embodiments, one objective of the methods provided herein is to minimize and / or prevent the process shown in Scheme IV. A similar reaction can occur with any reactive nucleophile, such as, for example, an amine, but such a reaction is not usually expected under the conjugation conditions.
[0069] It should be noted that PEG2-fulvene is not removed during conventional purification of the PEG-FMOC-NHS reagent, since the conventional purification process is a reprecipitation procedure that removes most small molecules but not other PEG polymeric impurities, a problem not previously addressed but which is addressed by the present disclosure, among other problems.
[0070] Among the numerous process improvements and improved materials described herein, the present disclosure provides, but is not limited to, the following: (i) improvements to processes for preparing reactive water-soluble polymeric FMOC reagents, such as C2-PEG2-FMOC-NHS; (ii) methods that replace the highly toxic reagent, phosgene (or its precursors, e.g., triphosgene) with safer reagents effective to form intermediates that can be readily converted to reactive polymeric FMOC N-hydroxysuccinimide (NHS) reagents (i.e., methods that are absent of phosgene or phosgene precursors); (iii) A method for the direct activation of 9-hydroxymethylfluorene polymers such as C2-PEG2-FMOC-OH with disuccinimidyl carbonate (DSC); (iv) a method for removing reactive PEG fulvene impurities prior to activation of polymeric hydroxymethylfluorene; (v) a method for stabilization of polymeric FMOC active carbonate reagents with acidic additives; and (vi) A method in which a conventional polymer-FMOC intermediate, such as a chloroformate (ClC(O)O~) or a BTC derivative, is used as a reagent in the formation of a polymer-FMOC-therapeutic agent conjugate, thereby minimizing the production of polymer-substituted fulvene and improving the yield of the polymer-FMOC therapeutic agent conjugate.
[0071] These and other aspects and embodiments are described in more detail in the following paragraphs.
[0072] method As described above, process improvements are provided herein that allow for the production of particularly reactive PEG-FMOC reagents. These discoveries were arrived at, at least in part, by first identifying the root cause of the reactivity pathways that can lead to the destruction of such reagents. Although hydrolysis of polymeric reagents generally provides a route for the destruction of active ester or active carbonate reagents, this pathway has already been considered (i.e., minimized) in previous descriptions of methods for making and recovering PEG-FMOC reagents (see, for example, Bentley, M., et al., U.S. Pat. No. 8,252,275). The method described herein focuses on the elimination process that leads to the formation of water-soluble polymeric fulvene by-products that can form as the main impurity in the water-soluble polymer-FMOC active carbonate product. The fulvene is formed from the reagent as shown in the illustrative scheme III above. Since the polymeric fulvene by-products are undesirable impurities in the reagents because they are reactive impurities rather than inert impurities, one of the objectives of the method provided herein is to remove or minimize the formation of the fulvene. To that end, a modified reaction process was developed by identifying several process reactive species that can lead to the formation of fulvene impurities, and then adding species that are effective to either (i) eliminate or remove those species, or (ii) neutralize the undesired reactive species so that they do not catalyze or otherwise lead to the formation of polymeric fulvene. A generalized reaction scheme is shown below as Scheme Va. [ka] wherein in each of the structures provided above, POLY a is a first water-soluble, non-peptidic polymer; POLY b is a second water-soluble, non-peptidic polymer; R e1 is the first electron changing group, if present; R e2 is a second electron transfer group, if present; L1 is a first linking moiety; and L2 is a second linking moiety; POLY a, POLY b , R e1 , R e2 , L1, and L2 are provided in more detail below.
[0073] In particular, the undesirable substances that most often lead to the formation of fulvene species from the polymeric reagent or from reactive intermediates that lead to the polymeric reagent are basic substances that are often present in the reaction process. Such substances can be any chemical species with atoms that tend to act as a base. For example, water may act as an acid or a base, and the tendency to act as one or the other is generally dependent on the pH of the medium. In the process of making the desired active carbonate polymeric FMOC reagent, the most commonly identifiable substance that can act as a base is pyridine or a similar type of basic substance. This chemical species acts to promote the formation of the final active carbonate reagent. Therefore, its inclusion or the inclusion of a similar species is usually utilized to provide favorable product yields. To prevent or minimize the reaction shown in Scheme IV, one of the approaches described herein is to remove (or substantially remove) the pyridine (or similar species) during product isolation or to neutralize this or a similar base to minimize its reactivity as a base. Thus, in one or more aspects or embodiments, an improved method for preparing water-soluble polymeric FMOC reagents, such as activated carbonates, includes one or more steps to remove basic species that are added to the process.
[0074] Furthermore, in one or more other aspects or embodiments of preparing a water-soluble polymeric FMOC reagent, such as an activated carbonate or precursor thereof, an acidic species is added to the reaction mixture after the reaction step, thereby neutralizing the pyridine or any other basic species added during the reaction process to facilitate product formation. In one or more embodiments, the acid is selected from, but is not limited to, acetic acid, trifluoroacetic acid, citric acid, sodium dibasic phosphoric acid, potassium hydrogen phosphate, sulfuric acid, m-nitrobenzoic acid, trichloroacetic acid, phosphoric acid, or any other inorganic or organic acidic species that does not cause adverse effects in the reactive carbonate product. In one or more specific embodiments, the acid added to the reaction mixture is selected from acetic acid, citric acid, and phosphoric acid.
[0075] For example, in a method for preparing a reactive polymeric FMOC active carbonate reagent, a water-soluble 9-hydroxylmethylfluorene polymer (e.g., any one of structures (I), (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), (Ih)) is reacted with a reagent useful for forming an active carbonate of the water-soluble fluorene polymer in the presence of a base, followed by recovery of the water-soluble polymeric 9-methylfluorene active carbonate by precipitation. Suitable reactants for forming the active carbonate or active carbonate precursor include, for example, dibenzotriazolyl carbonate, N-hydroxysuccinimide, chloroformates such as 4-nitrobenzyl chloroformate or 4-nitrophenyl chloroformate, and 1-hydroxybenzotriazole.
[0076] A representative water soluble 9-hydroxymethylfluorene polymer starting material is shown below: [ka] POLY a is a first water-soluble, non-peptidic polymer; POLY bis a second water-soluble, non-peptidic polymer; R e1 is, if present, a first electron changing group; and R e2 is a second electron changing group, if present; L1 is a first linking moiety; and L2 is a second linking moiety; [ka] R e1 and R e2 , L1 and L2 are as described above (and in more detail herein), and POLY a and POLY b wherein each n is mPEG and n is independently in the range of from about 3 to about 2273; [ka] L1 and L2 are as described above (and in more detail herein); POLY a and POLY b wherein each n is mPEG and n is independently in the range of from about 3 to about 2273; [ka] R e1 , L1, and L2 are as described above (and in more detail herein); and POLY a and POLY b wherein each n is mPEG and n is independently in the range of from about 3 to about 2273; [ka] POLY a and POLY b wherein each n is mPEG and n is independently in the range of from about 3 to about 2273; [ka] POLY a and POLY bis mPEG, and each n independently ranges from about 3 to about 2273; [ka] POLY a and POLY b is mPEG, and each n independently ranges from about 3 to about 2273; [ka] POLY a and POLY b is mPEG, each n is independently in the range of from about 3 to about 2273; and [ka] POLY a and POLY b In this case, is mPEG and each n independently ranges from about 3 to about 2273.
[0077] In general, the reaction is carried out under anhydrous conditions and in an anhydrous aprotic solvent. Typical aprotic solvents include, for example, halogenated aprotic solvents such as, for example, dichloromethane or trichloroethylene, or non-polar solvents such as benzene, chlorobenzene, nitrobenzene, xylene, cyclohexane, tetralin, and toluene. In some embodiments, a mixture of two solvents may prove superior to one alone and may therefore be preferred. In some embodiments, the solvent is an aprotic polar solvent that is effective in dissolving the polymeric starting material. Other aprotic solvents that may be used include, for example, dimethylformamide, acetone, acetonitrile, dioxane, tetrahydrofuran (THF), dimethylsulfoxide, HMPA (hexamethylphosphoramide), DMA (dimethylacetamide), and NMP (N-methylpyrrolidinone). Again, in some embodiments, a mixture of two or more solvents may be preferred. Aprotic solvents lack acidic hydrogen, i.e., they are not proton donors. However, some aprotic solvents tend to be slightly basic and therefore may not be a suitable choice. Those skilled in chemistry can easily determine other aprotic solvents suitable for use in the reactions described herein. In general, the selection of an appropriate solvent depends on the ability of the solvent to dissolve all components of the reaction without reacting with any reaction components or reaction products. On the other hand, the ability of the solvent to be used under anhydrous conditions is important, since in the reactions described herein, moisture should be minimized to protect moisture-sensitive reactants and products. Furthermore, the solvent may be used to co-distill with any moisture that may be present. Some solvents may be more convenient to remove moisture than others, as may be determined through routine experimentation using the guidance provided herein. In one or more embodiments, during the recovery step, the precipitating solvent contains an amount of acid (such as those described above) effective to partially or completely neutralize excess base present in the reaction mixture.
[0078] As some processes that are suitable for laboratories, where reactions are performed by skilled, highly educated chemists, move to production facilities, where reactions may be performed by skilled, but less highly educated workers, safety of technicians becomes a major concern. Thus, to address this concern, in one or more further aspects or embodiments, provided herein is a synthetic method that exchanges certain undesirable or dangerous to handle reagents, such as phosgene or its precursors (e.g., triphosgene), for safer to handle reagents that ultimately result in reactive N-hydroxysuccinimide (NHS) reagents. That is, in one or more aspects or embodiments, provided herein is a method for preparing water-soluble polymeric FMOC reagents, such as activated carbonates or intermediates useful for forming active esters, such as activated carbonates, that is performed without the use of phosgene or one of its precursors, as generally shown in Schemes Va or Vb above. Moreover, in some embodiments, a straightforward route to NHS carbonate is used, thus eliminating diBTC, which can be explosive under certain circumstances. Thus, in some further embodiments, neither a phosgene derivative nor diBTC is used to prepare the desired activated carbonate.
[0079] One such method for making water-soluble polymeric FMOC-activated carbonates includes dibenzotriazolyl carbonate (diBTC) as a reactant. DiBTC is explosive when handled as a dry powder, but is considered safe to handle as a suspension in certain halogenated solvents. Such suspensions are commercially available. Moreover, diBTC does not have the potential to release toxic gases, as does phosgene. As a result, in one or more further aspects or embodiments, methods are provided herein that use safer reagents, such as diBTC, to achieve the conversion of intermediate water-soluble polymeric hydroxymethylfluorene derivatives (see, for example, structure (I) or any one of structures (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), (Ih)) to the corresponding polymeric fluorene BTC-activated carbonates (see, for example, Schemes Va and b). Exemplary BTC carbonates are provided below. [ka] POLY a , POLY b , R e1 , R e2 , L1, and L2 are as described above (and in more detail herein); [ka] R e1 , R e2 , L1, and L2 are as described above (and in more detail herein); and POLY a and POLY b is mPEG, and each n independently ranges from about 3 to about 2273; [ka] L1 and L2 are as described above (and in more detail herein); POLY a and POLY bis mPEG, and each n independently ranges from about 3 to about 2273; [ka] L1 and L2 are as described above (and in more detail herein); POLY a and POLY b is mPEG, and each n independently ranges from about 3 to about 2273; [ka] Here, POLY a and POLY b is mPEG, and each n independently ranges from about 3 to about 2273; [ka] Here, POLY a and POLY b is mPEG, and each n independently ranges from about 3 to about 2273; [ka] Here, POLY a and POLY b is mPEG, and each n independently ranges from about 3 to about 2273; [ka] Here, POLY a and POLY b is mPEG, and each n is independently in the range of from about 3 to about 2273; and [ka] Here, POLY a and POLY b In this case, is mPEG and each n independently ranges from about 3 to about 2273.
[0080] In the method, a water soluble 9-hydroxymethylfluorene polymer having a structure such as (I) (or, for example, any one of structures (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), (Ih)) is reacted with dibenzotriazolyl carbonate under anhydrous conditions in the presence of a base in an anhydrous aprotic solvent to provide a reaction mixture comprising a water soluble 9-methylbenzotriazolyl carbonate fluorene polymer having structure (II) or, in one or more embodiments, for example, any one of structures (II-a), (II-b), (II-c), (II-d), (II-e), (II-f), (II-g), (II-h), and thereafter recovering the water soluble 9-methylbenzotriazolyl carbonate fluorene polymer by precipitation with an anhydrous solvent effective to promote precipitation of the water soluble 9-methylbenzotriazolyl carbonate fluorene polymer.
[0081] As described above, typical anhydrous aprotic solvents for carrying out the reaction include, for example, anhydrous halogenated aprotic solvents such as, for example, dichloromethane or trichloroethylene, or non-polar solvents such as benzene, chlorobenzene, nitrobenzene, xylene, tetralin, and toluene. Other anhydrous aprotic solvents that may be used include, for example, dimethylformamide, acetone, acetonitrile, dioxane, tetrahydrofuran (THF), dimethylsulfoxide, HMPA (hexamethylphosphoramide), DMA (dimethylacetamide), and NMP (N-methylpyrrolidinone). Other remarks found elsewhere in this application relating to choosing a solvent or mixture of solvents acceptable for a particular reaction also apply here. Those skilled in the art will be able to readily determine other suitable aprotic solvents for use in the reactions described herein. In some particular embodiments, the reaction solvent is an anhydrous chlorinated solvent such as dichloromethane or trichloroethylene. In yet some other embodiments, the reaction solvent is an anhydrous solvent selected from dimethylformamide, acetone, acetonitrile, and tetrahydrofuran. In some related embodiments, prior to reaction, the water-soluble 9-hydroxymethylfluorene polymer is dissolved in an aprotic organic solvent to form a solution, followed by azeotropic distillation of the solution to yield a solution and / or residue having a water content of less than 500 ppm. Other approaches for preparing anhydrous solvents and / or anhydrous polymeric reactants, intermediates, or reagents and / or for providing anhydrous reaction conditions are described elsewhere herein.
[0082] The reaction includes a sufficient amount of di-BTC to achieve formation of BTC carbonate. Generally, a sufficient amount of di-BTC is less than about 30 equivalents. For example, in some embodiments of the method, the water-soluble 9-hydroxymethylfluorene polymer is reacted with less than about 30 equivalents of di-BTC. For example, the water-soluble 9-hydroxymethylfluorene polymer may be reacted with from about 1 equivalent to about 30 equivalents (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 1, 16, 17, 18, 19, 20, 21 22, 23, 24, 25, 26, 27, 28, 29, or 29.9 equivalents, including any and all ranges between any two of the foregoing values) of di-BTC. For example, the amount can be from about 1 to about 25 equivalents of di-BTC, or from about 1 to 20 equivalents of di-BTC, or from about 1 to 15 equivalents of di-BTC, or from about 1 to 10 equivalents of di-BTC. Other suitable amounts of di-BTC reagent relative to the water soluble 9-hydroxymethylfluorene polymer are from about 2 to about 20 equivalents, from about 5 to about 15 equivalents, or from about 10 to 20 equivalents.
[0083] Generally, the base used in the reaction is a non-nucleophilic amine or a slightly nucleophilic amine. For example, illustrative bases that may be used include pyridine, 4-dimethylaminopyridine, N,N-diisopropylethylamine, 2,6-di-tert-butylpyridine, N-methylimidazole, N-methylmorpholine, 2,6-lutidine, 2,4,6-collidine, N,N,2,6-tetramethylpyridin-4-amine, and the like. Moreover, insoluble polymer-bound forms of any of the aforementioned bases may also be used. For example, polymer-bound 4-dimethylaminopyridine is available from Sigma-Aldrich (approximately 3 mmol / g loading, matrix cross-linked with 2% divinylbenzene); polymer-bound 2,6-di-tert-butylpyridine (approximately 1.8 mmol / g loading, 1% cross-linked with divinylbenzene) is also available from Sigma-Aldrich, in addition to many other polymer-supported bases. The amine may also be a polyamine such as, for example, N,N,N',N'-tetramethyl-1,6-hexamethyldiamine, N,N',N',N",N"-pentamethyldiethylenetriamine, and hexamethylenetetramine, or an insoluble polymer-bound form of any of the foregoing. In one or more embodiments of the method, the amount of base ranges from about 1 to about 30 equivalents or from about 1 to about 10 equivalents. More specifically, the reaction may be carried out with about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 1, 16, 17, 18, 19, 20, 21 22, 23, 24, 25, 26, 27, 28, 29, or 30 equivalents of base, the foregoing including any and all ranges between any two of the foregoing values. The optimal amount of base for any particular process is best determined by experimentation. The lowest amount of base required to give the highest reaction yield is preferred.
[0084] The reaction may be carried out with or without mechanical stirring. Usually, but not necessarily, the reaction is carried out with mechanical stirring. Mechanical stirring is especially recommended for large scale reactions to facilitate proper mixing. Generally, the water-soluble 9-hydroxymethylfluorene polymer is reacted with the dibenzotriazolyl carbonate at a temperature ranging from about -20°C to about 35°C. Other typical temperature ranges include about -10°C to about 25°C or about -5°C to about 10°C.
[0085] Now, regarding the recovery of the water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer, in some embodiments, both the water-soluble 9-hydroxymethyl fluorene polymer and the corresponding water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer product are soluble in an aprotic organic solvent. Thus, in some embodiments, the resulting reaction mixture contains solids, and the recovery of the product includes first removing the solids contained in the reaction mixture, followed by recovering the benzotriazolyl carbonate product. For example, the solids contained in the reaction mixture may be removed by any suitable method using the best technique. For example, the solids may be removed by filtration. After the removal of the solids, an anhydrous precipitating solvent is then typically added to the remaining solution (or the filtrate, if the solids are removed by filtration) in an amount effective to precipitate the benzotriazolyl carbonate product. Alternatively, after the removal of the solids, the remaining benzotriazolyl carbonate product is added to the anhydrous precipitating solvent. That is, an anhydrous precipitating solvent may be added to the polymer product, the benzotriazolyl carbonate, or the polymer product may be added to the anhydrous precipitating solvent to achieve precipitation. In some cases, the anhydrous precipitating solvent is miscible with the anhydrous aprotic organic solvent of the reaction step and is also a solvent in which the 9-methylbenzotriazolyl carbonate fluorene product is insoluble or substantially insoluble.
[0086] In one or more embodiments, the anhydrous solvent incorporated to promote precipitation of the BTC ester product may include an acid. In one or more embodiments, the acid is selected from, but is not limited to, acetic acid, trifluoroacetic acid, citric acid, dibasic sodium phosphate, potassium hydrogen phosphate, sulfuric acid, m-nitrobenzoic acid, chloroacetic acid, trichloroacetic acid, phosphoric acid, or any other inorganic or organic acidic species that does not cause adverse effects in the reactive carbonate product. In one or more specific embodiments, the acid added to the reaction mixture is selected from acetic acid, citric acid, and phosphoric acid. In some preferred embodiments, the acid is phosphoric acid. The acid is generally added in an amount sufficient to partially or completely neutralize the base contained in the reaction mixture. In some embodiments, the amount of acid added to the anhydrous solvent to promote precipitation of the water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer includes a small amount of acid. For example, the anhydrous solvent may include about 0.0001 to about 0.5 mole percent of the acid. For example, the anhydrous precipitating solvent may contain from about 0.0002 to about 0.4 mole percent acid, or from about 0.0010 to about 0.4 mole percent acid, or from about 0.0050 to about 0.3 mole percent acid. The exact amount of acid used in a particular process is selected based on the anticipated amount of base to be neutralized and is best determined by experimentation.
[0087] Exemplary precipitation solvents can be determined by those skilled in the art and include aliphatic hydrocarbons and other non-reactive miscible solvents in which the BTC ester product is insoluble or substantially insoluble. Illustrative precipitation solvents include, for example, diethyl ether, isopropyl alcohol (IPA), methyl-t-butyl ether (MTBE), pentane, hexane, and heptane, as well as mixtures of any two or more of the foregoing. One exemplary mixture is a mixture of isopropyl alcohol and methyl-t-butyl ether. One such preferred mixture is a 1:1 mixture of isopropyl alcohol and methyl-t-butyl ether, although any combination of the two solvents may be used.
[0088] After recovery of the precipitated BTC ester product, for example by filtration, the recovered product may be further washed with an anhydrous precipitating solvent, i.e., a solvent in which the BTC ester is insoluble or substantially insoluble, which may contain a small amount of acid, for example, about 0.0001 to about 0.5 mole percent acid. For example, washing of the recovered FMOC polymeric product with an anhydrous precipitating solvent (also referred to as a "non-solvent") may further contain an antioxidant, such as butylated hydroxyl toluene (BHT), to avoid oxidative degradation. The recovered product may then be further dried, if desired, and / or further purified using standard well-known methods for purifying water-soluble polymeric reagents. One such particularly preferred method is chromatography, for example, size exclusion chromatography.
[0089] Example 1 provides an illustration of the reaction and related processing steps described above. See Example 1B, which describes the preparation of G2-PEG2-FMOC-BTC-20kD from the corresponding G2-PEG2-FMOC-OH-20kD. As described therein, after dissolving G2-hydroxymethylfluorene polymer in anhydrous dichloromethane and anhydrous toluene, the solvent is then removed by distillation to remove water, and then dissolved in anhydrous acetonitrile. After reacting di-BTC and G2-hydroxymethylfluorene polymer, the product is precipitated by the addition of anhydrous isopropyl alcohol (containing butylhydroxytoluene), collected by filtration, further washed with a non-solvent (e.g., isopropyl alcohol and diethyl ether), and dried under vacuum.
[0090] Example 3, part 2, IB, describes the preparation of C2-PEG2-FMOC-BTC-20kD from the corresponding C2-PEG2-FMOC-OH-20kD. Briefly, C2-PEG2-FMOC-OH-20kD was dissolved in anhydrous solvent, toluene, and then dried by azeotropic distillation of the solvent under reduced pressure. This process was then repeated. The dried C2-PEG2-FMOC-OH-20kD was then dissolved in anhydrous acetonitrile, the solution was cooled (e.g., to 5° C.), and then di-BTC and a base, pyridine, were added. The mixture was then stirred for several hours. After the reaction, the mixture was added to a solution of chilled isopropyl alcohol containing an acid, phosphoric acid (0.005%). The mixture was then mixed further and chilled MTBE containing phosphoric acid (0.005%) was added to the mixture, followed by further stirring to facilitate precipitation. The precipitated product was then collected by filtration and washed multiple times with a mixture of IPA / MTBE containing phosphoric acid, with the subsequent washes containing slightly less phosphoric acid (e.g., 0.005% and 0.002%). The product was then dried under vacuum at low temperature, 15°C.
[0091] Although the BTC derivative itself may be used to react with a protein or other suitable active agent to form a polymer-active agent conjugate, when a more active carbonate, such as N-hydroxysuccinimidyl (NHS) carbonate (sometimes referred to as an active ester), is used, the corresponding biotherapeutic agent conjugate is usually formed quickly. Thus, in yet one or more other aspects or embodiments, methods are provided in which a polymeric FMOC-BTC derivative, such as a derivative of structure (II) or, for example, any one of structures (II-a) to (II-h), is used as an intermediate that may be converted to a desired NHS active carbonate ester having a generalized structure, such as, for example, (X) (see, for example, Scheme VI). Particular PEG2 FMOC-NHS esters are shown in structures (XI), (XII), (XIII), and (XIV). A preferred NHS ester is shown in structure (XIV). The specific reaction conditions for converting the polymeric FMOC-BTC ester to the corresponding reactive NHS ester shown in the illustrative Scheme Vb below (e.g., acetonitrile solvent, pyridine base, N-hydroxysuccinimide (NHS) reagent; or e.g., dichloromethane solvent, dimethylaminopyridine, NHS) are intended to be illustrative; suitable solvents, bases, coupling reagents or other additional reagents and reaction conditions for converting the water-soluble polymeric FMOC BTC carbonate (or other less reactive carbonates) to the corresponding NHS carbonate can be readily determined by those of skill in the art. For example, the conversion reaction may be carried out using about 1 to about 30 equivalents of NHS. Other illustrative amounts of NHS reagent include, for example, about 1 to about 25 equivalents, about 2 to about 20 equivalents, about 3 to about 15 equivalents, and about 5 equivalents to about 15 equivalents. Typically, the reaction temperature is maintained at about -20°C to about 25°C during the addition of the NHS reagent. Illustrative reaction temperature ranges are selected from, for example, about -15°C to about 20°C, about -10°C to about 10°C, about -10°C to about 0°C, about -8°C to about 5°C, and about -7°C to about 0°C. In some embodiments, the temperature is in the range between about -10°C to about 10°C.The optimal temperature for a particular reaction can be determined by experiment. In some embodiments, the conversion of the polymeric FMOC-BTC ester to the NHS ester by reaction with NHS is carried out in dichloromethane in the presence of dimethylaminopyridine. Suitable amounts of dimethylaminopyridine to facilitate the conversion range, for example, from about 4 equivalents to about 0.10 equivalents, from about 3 equivalents to about 0.15 equivalents, from about 2 equivalents to about 0.20 equivalents, from about 1 equivalent to about 0.40 equivalents, and from about 0.75 equivalents to about 0.50 equivalents. In some embodiments, DMAP is present in an amount of from about 2 equivalents to about 0.20 equivalents. In some other embodiments, DMAP is present in an amount of from about 1 equivalent to about 0.4 equivalents. In some other embodiments, DMAP is present in an amount of from about 0.75 equivalents to about 0.50 equivalents. All processes in which the activated carbonate is prepared, isolated, purified, or handled are preferably carried out in a very dry environment, preferably in a glove box covered with dry nitrogen or argon, or in an ultra-low humidity laboratory. Furthermore, all solvents and reagents should preferably be of high quality and maintained in a dry environment before use. If drying techniques are used to remove moisture before the reaction, a moisture analysis is usually performed to ensure that the moisture level is as low as can be reached using the particular procedure. In replicate experiments, if the moisture removal process is verified, the moisture analysis may be omitted. After preparation of the polymeric FMOC-NHS ester, the polymeric FMOC-NHS ester may be recovered and further processed as described below. [ka]
[0092] See, for example, Example 1C, where an illustrative 9-methylbenzotriazolyl carbonate fluorene PEG polymer, G2-PEG2-FMOC-BTC-20kD, is converted to the corresponding succinimidyl ester according to the methods provided herein. As described in the examples, G2-PEG2-FMOC-BTC-20kD is dissolved in anhydrous solvent, dichloromethane, and the solution is then cooled (to 8°C). N-hydroxysuccinimide is then added to the cooled solution, and the reaction mixture is stirred at 8°C overnight. The resulting NHS ester product is then recovered by precipitation with isopropyl alcohol (containing citric acid and an antioxidant, BHT), isolated by filtration, and then further washed with a non-solvent (first with anhydrous isopropyl alcohol (containing BHT), followed by anhydrous methyl-tert-butyl ether containing citric acid and BHT), followed by drying under vacuum. To determine the percent substitution of active carbonate, a reaction with glycine was carried out and then analyzed. Notably, the NHS ester prepared and processed as described above had a substitution percentage of 88.1 mole percent; after storage at 11° C. for 136 hours, the product showed a substitution percentage of 86.6 mole percent (a loss of about 1-2%). In contrast, a similar NHS ester product prepared but precipitated without the addition of acid to the solvent, isopropyl alcohol, and further without the presence of acid in the methyl tert-butyl ether wash, was found to have some substitution after preparation, such as 86.2 mole percent (slightly less than the method of the present invention). However, after storage at 11° C. for 136 hours, the stored product was determined to have a substitution percentage of 75.3 mole percent (i.e., a loss of about 11% product). Thus, the process improvements described herein are effective in providing active fluorene polymer NHS ester reagents with better stability upon storage, for example, by using an acidic additive during recovery and processing of both the intermediate and the active carbonate reagent.
[0093] This process is also further exemplified in Example 3, part 2, IC, which describes the preparation of C2-PEG2-FMOC-NHS 20 kD from C2-PEG2-FMOC-BTC 20 kD.
[0094] Since water-soluble polymeric FMOC-activated NHS carbonates (esters) may be even more highly desirable as reagents for conjugation with active agents, such as proteins, to form polymeric prodrugs, in one or more further aspects or embodiments, methods are also provided herein for the direct activation of C2-PEG2-FMOC-OH (or any other water-soluble 9-hydroxymethylfluorene polymers described herein) with disuccinimidyl carbonate (DSC) to yield the corresponding NHS-activated carbonates. Illustrative polymeric starting materials include those described by structures (I), (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), and (Ih), and the corresponding NHS-activated carbonates correspond to each of the foregoing structures, where the 9-methylhydroxyl protons are exchanged with ~C(O)O-succinimide. Similarly, illustrative products, i.e., NHS carbonates, include those having structures (III), (X), (XI), (XII), (XIII), (XIV). See generalized Schemes VIa and VIb below, where Scheme VIa illustrates the subject reaction for a generalized water-soluble 9-hydroxymethylfluorene polymer, while Scheme VIb shows the same reaction for a preferred water-soluble PEG-2 9-hydroxymethylfluorene polymer having a C2 core. [ka]
[0095] This process can be productive under a variety of conditions, and numerous conditions were explored to find the optimum. In one or more embodiments, the polymeric hydroxymethylfluorene derivative, such as C2-PEG2-FMOC-OH (or having structures such as structures (I), (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), and (Ih)), is dissolved in a suitable anhydrous solvent. Typical solvents include aprotic organic solvents, such as chloroform, dichloromethane, acetonitrile, dimethylformamide, dioxane, acetone, tetrahydrofuran, and the like, including mixtures of the foregoing. In some embodiments, the aprotic organic solvent is a polar aprotic solvent. Preferably, the polymeric hydroxymethylfluorene derivative is soluble in the aprotic organic solvent. The resulting solution may then be further dried, for example by using commonly used methods, to remove any traces of water that may hydrolyze the highly reactive carbonate reagent. Such methods are well known in the art and include, for example, the use of an inert, dry atmosphere such as nitrogen or argon, the use of drying agents such as molecular sieves, sodium sulfate, magnesium sulfate, calcium chloride, calcium sulfate, and the like, azeotropic distillation. The drying process may then be preferably repeated until the moisture content remains constant as measured by standard moisture titration methods or other methods known in the art. (See Pangborn et al.; and Williams et al.; supra.) Ideally, the process is repeated until less than about 500 ppm moisture is achieved. For example, drying may be repeated until a dried polymer solution having a moisture content of less than about 400 ppm is reached, or more preferably, less than about 300 ppm moisture is reached. Most preferably, drying is repeated until less than about 200 ppm moisture is reached. In some embodiments, the drying of the solvent includes one or more azeotropic distillations. In some cases, it may be determined by experimentation that some solvents or solvent mixtures result in lower moisture than others.Disuccinimidyl carbonate (DSC) is then added while working under a dry and inert environment (e.g., nitrogen, argon, helium). The DSC is typically added in a ratio of about 1-20 equivalents. For example, the number of DSC equivalents may be selected from 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, and 20. Illustrative amounts of DSC reagent include, for example, about 1 to about 15 equivalents, or about 2 to about 10 equivalents, or about 2 to about 7 equivalents, or about 2 to about 5 equivalents. The minimum amount of DSC for a particular reaction, e.g., to provide the highest product yield and quality, should be used as can be determined by experiment. Typically, the reaction temperature is maintained at about 0-30° C. during the addition of the DSC reagent. Illustrative reaction temperature subranges are selected from, for example, about 0-25°C, about 0-20°C, about 0-15°C, about 5-30°C, about 5-25°C, about 5-20°C, and about 10-30°C. Again, the optimal temperature for a particular reaction can be determined by experimentation. Once the addition of the DSC reagent is complete, the temperature may then be adjusted to approximately 7.5-18°C, if necessary, prior to the addition of the base. The base is then added to the solution containing the polymeric hydroxymethylfluorene derivative. For example, about 1 to about 30 equivalents of base are added, or preferably about 2 to about 20 equivalents of base are added, or about 1 to 15 equivalents of base or more preferably about 3 to 10 equivalents of base are added. Suitable bases include amines; preferably, the base is a non-nucleophilic amine or a slightly nucleophilic amine. Suitable bases include, for example, pyridine, 4-dimethylaminopyridine, N,N-diisopropylethylamine, 2,6-di-tert-butylpyridine, N-methylimidazole, N-ethylisopropylamine, 2,6-lutidine, 2,4,6-collidine, N,N,2,6-tetramethylpyridin-4-amine, and insoluble polymer-bound forms of any of the foregoing (described above). Additionally, the base may be a polyamine, such as, for example, N,N,N',N'-tetramethyl-1,6-hexamethyldiamine, N,N',N',N",N"-pentamethyldiethylenetriamine, hexamethylenetetramine, and insoluble polymer-bound forms of the foregoing polyamines.
[0096] In one or more particular embodiments, the base is pyridine or 4-dimethylaminopyridine. Those skilled in the art will have knowledge of the types of bases that may be used. The appropriate base for use in preparing the highest quality product of a particular polymeric hydroxymethylfluorene activator carbonate can be easily determined by experiment, for example, using the guidance provided herein.
[0097] The reaction (i.e., conversion to NHS carbonate) is then carried out, preferably with stirring / mixing, while maintaining the temperature of the solution in the temperature range of about 3-21° C. The reaction may take from a few minutes to a few hours, depending on the structure of the polymeric reactants, the reaction temperature, the particular solvent, the stirring speed, and other factors. Once the reaction is complete (the progress of the reaction can be monitored by any suitable means, e.g., 1 The base can then be neutralized or partially neutralized by monitoring the disappearance of the polymeric hydroxymethylfluorene starting material by any suitable analytical technique, such as H NMR or by monitoring the reaction exotherm using an on-board thermocouple). The solution is typically maintained at a temperature ranging from about 3 to 15° C., and an acid is added to neutralize or partially neutralize the base (e.g., pyridine or the like). Typical acids include, for example, acetic acid, phosphoric acid, citrus acid, dibasic sodium phosphate, potassium hydrogen phosphate, sulfuric acid, chloroacetic acid, meta-nitrobenzoic acid, trifluoroacetic acid, trichloroacetic acid, p-toluenesulfonic acid, or the like. In some embodiments of the method, the acid is acetic acid, citric acid, or phosphoric acid.
[0098] After a suitable time for the acid-base reaction to subside, the reaction mixture can be filtered through a suitable filter (to remove solids) into a sufficient volume of anhydrous precipitating solvent, preferably cold, i.e., above its freezing point but below room temperature (e.g., 20-25° C.). The precipitating solvent is generally an anhydrous, non-reactive solvent in which the NHS carbonate product is insoluble or substantially insoluble (as defined above). Precipitating solvents include, for example, solvents such as diethyl ether, isopropyl alcohol, methyl t-butyl ether, and the like, as well as aliphatic hydrocarbons, such as hexane and heptane, and mixtures of the foregoing. Upon introduction of or into the cold, anhydrous precipitating solvent, the desired NHS ester product precipitates out of solution, usually as a solid. The precipitating solvent may preferably contain a small but suitable amount of an acidic species (e.g., chloroacetic acid or phosphoric acid) to neutralize any remaining base contained within the mixture. In one or more embodiments, the acid is selected from, but is not limited to, acetic acid, trifluoroacetic acid, citric acid, dibasic sodium phosphate, potassium hydrogen phosphate, sulfuric acid, m-nitrobenzoic acid, chloroacetic acid, trichloroacetic acid, phosphoric acid, p-toluenesulfonic acid, or any other inorganic or organic acidic species that does not cause undesirable effects in the reactive NHS carbonate product. In one or more specific embodiments, the acid is selected from chloroacetic acid or phosphoric acid. In some preferred embodiments, the acid is phosphoric acid. The acid is generally added in an amount sufficient to partially or completely neutralize the base contained in the mixture. In some embodiments, the amount of acid added to the anhydrous solvent to promote precipitation of the water-soluble 9-methyl-N-hydroxysuccinimidyl carbonate fluorene polymer includes a small amount of acid. For example, the anhydrous precipitating solvent may include about 0.0001 to about 0.5 mole percent of the acid. For example, the anhydrous precipitating solvent may contain from about 0.0002 to about 0.4 mole percent acid, or from about 0.0010 to about 0.4 mole percent acid, or from about 0.0050 to about 0.3 mole percent acid. Higher mole percentage amounts of acid may be required for unusual reactions in a particular solvent.The optimum amount of a particular acid is preferably determined by experimentation, with the lowest amount of acid for a given application being preferred.
[0099] The mixture may then be further processed by stirring with cold anhydrous non-solvent material (i.e., a solvent in which the product is insoluble or substantially insoluble), such as ethyl ether or methyl t-butyl ether, containing a small amount of acidic species, such as the same acid as that used earlier in the process, e.g., chloroacetic acid or phosphoric acid or the like, as described above. The precipitated product is then typically isolated, e.g., by filtration. As noted earlier, all process steps should be carried out in an environment that minimizes moisture exposure. The filtered product is then preferably further washed with more anhydrous non-solvent, e.g., ether, e.g., diethyl ether or methyl-t-butyl ether, or other suitable precipitating solvent, as described above. The washing solvent typically contains a small amount of acidic species, as described above. Washing of the recovered FMOC polymeric material, e.g., with anhydrous precipitating solvent, may further include an antioxidant, e.g., butylated hydroxyl toluene (BHT), to avoid oxidative degradation of the polymer chains, if PEG is the polymer used. The isolated product may then be further dried, for example, by drying under reduced pressure (i.e., vacuum drying). Moreover, the isolated NHS carbonate product may be further purified by using standard well-known methods for purifying water-soluble polymeric reagents. One such purification method is reprecipitation. Another such preferred method is chromatography, for example, size exclusion chromatography.
[0100] As a further illustration of the methods and processes provided herein, Example 3, part 2, II describes the direct synthesis of an exemplary activated carbonate, C2-PEG2-FMOC-NHS-20kD, 20kD, from C2-PEG2-FMOC-OH.
[0101] The successful preparation of an exemplary brominated FMOC polymer, Br-G2-PEG2-FMOC-NHS-20k, using the methods provided herein is described in Example 2. Thus, in one or more embodiments, provided herein are FMOC starting materials, intermediates, and activated carbonates with one or two bromo groups substituted on the fluorene core, as shown in the following illustrative structures: [ka]
[0102] Further examples of brominated FMOC polymers include brominated versions of each of structures XI, XII, XIII, XIV, ID, Ie, If, Ig, Ih, II-d, II-e, II-f, II-g, and II-h.
[0103] Since the resulting polymeric FMOC-NHS carbonate reagents are susceptible to hydrolysis (Scheme VII, path A) to form the parent hydroxymethylfluorene derivatives, and also to potential thermal elimination reactions of such activated bases to form the corresponding fulvene derivatives (Scheme VII, path B), which have not yet been observed (see Meng et al. J. Am. Chem. Soc., 1997, 119, 4834-4840), the NHS reagents are preferably further protected by storage at low temperatures, e.g., below −40° C., more preferably below −70° C., under a dry, inert atmosphere, if storage exceeds one week. Moreover, samples should ideally be packed and shipped on dry ice, since unprotected shipping conditions may expose the reagents to unacceptably high temperatures, especially during summer months.
[0104] Considering now alternative routes for loss of reactivity of the subject polymeric FMOC reagents (other than those involving basic species as described above): polymeric PEG impurities are typically removed using chromatographic methods. See, for example, McManus, S., et al., U.S. Pat. No. 8,604,159. For example, the PEG carboxylic acid intermediate may be separated from the neutral polyethylene glycol by chromatography using a resin such as an appropriate chromatographic medium. In the case of fulvene formed as an impurity in the formation of the water-soluble polymer-FMOC-NHS reagent, if the fulvene is present in sufficient amounts to cause concern, another purification step may be added to the process to remove the fulvene impurity. Thus, if desired, the recovered water-soluble 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymer may be dissolved in an anhydrous solvent and the resulting solution passed through a resin column containing thiol groups to remove the polymeric fulvene by a reactive filtration process, see Tripp et al., Org. Lett., (2000), 2, 195-198. Resins containing attached thiol groups have been used by Dujardin, et al., Reactive and Functional Polymers (2000), 43, 123-132, to remove impurities. Such resins are commercially available and include, for example, TENTAGEL® S SH Standard thiol resin (Rapp Polymere, Tuebingen, Germany or Advanced Chemtech, Louisville, KY) and ISOLUTE® Si-Thiol (Uppsala, Sweden). While this reactive filtration process remains a method for purification of the reactive polymeric reagents described herein, the more reactive 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymer may react with the thiol resin by replacing the thiol of the succinimide moiety, leaving the fluorene polymer attached to the resin, thus reducing product recovery.Therefore, overall, it will be more economical, where possible, to carefully apply the reaction, recovery, and purification processes described elsewhere herein to instead provide the subject polymeric reagents with fewer amounts of polymeric fulvene by-products.
[0105] Regarding the possibility of fulvene formation during the preparation of PEG2-FMOC reagents, such as G2 series, with linkers (L in Scheme I) that result in a decrease in the acidity of the 9-position proton of the fluorene ring, there is usually no need to pay special attention during the preparation process.G2 and other more stable PEG FMOC reagents are not particularly unstable during their isolation, but it is preferable to take care to neutralize all bases, such as pyridine, that may still be present at the end of the process.In addition, washing the solid product after filtration with a non-solvent containing a small amount of acid may provide an advantage against potential problems that may occur during storage.
[0106] For more reactive intermediates and reagents, such as the C2 reagent, special measures are required to prevent loss of reagent activity during product isolation and storage. Thus, the processes described herein may be carried out, for example, to minimize moisture, since water can easily hydrolyze the reactive NHS carbonate and BTC intermediates. Even if special precautions are taken to minimize the presence of basic substances (elimination initiators or catalysts), loss of reagent activity will generally occur unless an acid such as trifluoroacetic acid or phosphoric acid or the like is included for neutralization of basic species during work-up and washing steps. Losses can also occur during product storage, even when the reagents are stored as solids at low temperatures, since molecules that are residual processes, such as pyridine, DMAP, and even water, can cause product degradation during storage. Thus, it is preferred to implement the measures described herein to exclude or neutralize moisture and basic species during product isolation and purification, as described herein. Moreover, to ensure that new basic substances (charged or uncharged) are not incorporated into the final packaged (e.g. bottled) reagent (product), the product should ideally be handled carefully during drying (e.g. under high vacuum) and bottling (e.g. in a dry box under an inert atmosphere). Finally, the bottled reagent should preferably be stored at low temperature, e.g. below -40°C, preferably below -70°C, until use.
[0107] Since the elimination process that produces PEG2fulvene is a very important route for the decrease of reagent activity, and since the elimination process leads to reactive impurities as described above, alternative reagents and methods are provided herein that will lead to a better conjugate yield, although they will lead to a total final product.FMOC NHS carbonate reagents may be advantageous because they are generally preferred in reactions with proteins or polypeptides to form PEG-drug conjugates.However, since the NHS component leaving group is a more favorable leaving group than chloride (from the respective chloroformate) or 1-hydroxybenzotriazole (from the respective BTC carbonate), it can be expected that under similar circumstances, NHS carbonate may lead to the formation of a greater amount of fulvene (when compared to chloride or 1-hydroxybenzotriazolyl leaving groups), since its route is comparatively more favorable.
[0108] Thus, if the protein to be conjugated has a highly reactive nucleophilic nitrogen (amine or other), reaction with PEG2-FMOC-chloroformate or other reactive carbonates (e.g., BTC carbonate) may be carried out to form the same or similar conjugates as those formed by reaction with PEG2-FMOC-NHS reagents. The overall results produced by reaction with non-NHS ester reagents should be viewed favorably, since the resulting conjugates are expected to have the same release properties regardless of the reactive carbonate reagent used, provided that the yield of the conjugate product is the same or better than that of NHS-carbonate reagents. Here, for example, if a chlorocarbonate or BTC carbonate polymeric reagent shows a smaller loss of reagent activity (e.g., due to undergoing a more gradual and therefore less productive conversion to the corresponding fulvene derivative compared to NHS ester reagents), the amount of intact active carbonate reagent remaining for reaction with the protein will be greater. Thus, the yield of the conjugate will theoretically be higher. That is, the choice of leaving group in a reactive polymeric reagent is a factor that should be considered in some cases to affect losses of the reagent during one or more of preparation, storage, and thereafter, as well as in some cases to affect the yield of conjugate that can be formed per mole of reagent prepared and ultimately delivered to a customer.
[0109] As described above, active agent conjugates can be prepared by reaction with the polymeric reagents prepared by the methods described herein. Generally, the biologically active agents to which the polymeric reagents prepared by the methods described herein are conjugated are amine-containing biologically active agents. In some embodiments, the biologically active agents are small molecules (e.g., biologically active agents having a molecular weight of less than about 3,500 daltons). In other embodiments, the biologically active agents are macromolecules, such as polypeptides, having a molecular weight of greater than about 3,500 daltons. Pharmacologically active polypeptides are a preferred type of biologically active agent. For purposes of discussing the present invention, it should be understood that the term "polypeptide" is a general term for oligopeptides and proteins. With respect to polypeptides, the amine to which the active polymeric reagent couples can be the N-terminus and / or amine-containing side chain of an amino acid (such as lysine) within the polypeptide. Methods for conjugating reactive polymeric reagents, such as those described herein, to biologically active agents are known to those of skill in the art.
[0110] The polymeric reagents prepared according to the methods described herein will preferably not contain polymeric fulvene by-products or will be substantially free of polymeric fulvene by-products. Illustrative polymeric reagents prepared according to the methods provided herein contain less than 15 mole percent polymeric fulvene impurities, or preferably less than 10 mole percent polymeric fulvene impurities. More preferably, the polymeric reagents prepared according to the methods provided herein contain less than 8 mole percent polymeric fulvene impurities or less than 7 mole percent polymeric fulvene impurities. Even more preferably, the polymeric reagents prepared according to the methods provided herein contain less than 5 mole percent polymeric fulvene impurities.
[0111] Exemplary structures of water-soluble 9-hydroxymethylfluorene polymers for forming polymeric activated carbonates or intermediates for forming activated carbonates, as well as exemplary structures of polymeric intermediates and activated carbonates themselves are provided herein. The following description of water-soluble polymers, electron transfer groups, and linking moieties is applicable not only to 9-hydroxymethylfluorene polymers, but also to reactive carbonates formed indirectly or directly therefrom and corresponding conjugates formed using the polymeric reagents resulting from the methods disclosed herein.
[0112] With respect to the structures provided herein, POLY a is a first water-soluble, non-peptidic polymer; POLY b is a second water-soluble, non-peptidic polymer; R e1 is, if present, a first electron changing group; and R e2 is a second electron changing group, if present; L1 is a first linking moiety; and L2 is a second linking moiety; the first and second electron changing groups, R e1 and R e2 For the zero subscript, e.g., [R e1 ]0 or [R e2 ]0 indicates that the electron transfer group is absent (or nonexistent), and a subscript of 1, e.g., [R e1 ]1 or [R e2 ]1 indicates the presence of an electron transfer group.
[0113] With respect to a particular water-soluble polymer, so long as the polymer is water-soluble and non-peptidic, each water-soluble polymer (e.g., POLY a , POLY b) can include any polymer. Although preferably poly(ethylene glycol), the water-soluble polymer can be, for example, other water-soluble polymers, such as other poly(alkylene glycols), such as poly(propylene glycol) ("PPG"), copolymers of ethylene glycol and propylene glycol, and the like, poly(olefin alcohols), poly(vinylpyrrolidone), poly(hydroxyalkyl methacrylamides), poly(hydroxyalkyl methacrylates), poly(saccharides), poly(α-hydroxy acids), poly(vinyl alcohols), polyphosphazenes, polyoxazolines, poly(N-acryloylmorpholines), and the like, such as those described in U.S. Pat. No. 5,629,384. The water-soluble polymer can be a homopolymer, copolymer, terpolymer, non-random block polymer, and random block polymer of any of the foregoing. In addition, the water-soluble polymer can be linear, as described in more detail below, but can also be other morphologies (e.g., branched, forked, and the like). Each water-soluble polymer in the overall structure can be the same or different. However, it is preferred that all water-soluble polymers in the overall structure are of the same type. For example, it is preferred that each of all water-soluble polymers in a particular structure is a poly(ethylene glycol). Furthermore, for a particular poly(ethylene glycol), each poly(ethylene glycol) can be end-capped with an end-capping moiety selected from the group consisting of hydroxyl, alkoxy, substituted alkoxy, alkenoxy, substituted alkenoxy, alkynoxy, substituted alkynoxy, aryloxy, and substituted aryloxy. A preferred end-capping group is methoxy.
[0114] Although the weight average molecular weight of any individual water-soluble polymer can vary, the weight average molecular weight of any particular water-soluble polymer reactant, intermediate, or activated carbonate (i.e., the entire polymeric FMOC structure) will typically be in the range of from about 100 Daltons to about 200,000 Daltons, or from about 100 Daltons to about 150,000 Daltons.However, typical ranges include the following ranges of weight average molecular weight: from about 880 daltons to about 5,000 daltons (e.g., each (n) ranges from about 10 to about 57); from greater than 5,000 daltons to about 100,000 daltons (e.g., each (n) ranges from about 58 to about 1136); from about 6,000 daltons to about 90,000 daltons (e.g., each (n) ranges from about 68 to about 1022); from about 10,000 daltons to about 85,000 daltons (e.g., each (n) ranges from about 10 to about 57); each (n) ranges from about 113 to about 966); in the range of greater than 10,000 daltons to about 85,000 daltons (e.g., each (n) ranges from about 114 to about 966); in the range of about 20,000 daltons to about 85,000 daltons (e.g., each (n) ranges from about 227 to about 966); in the range of about 53,000 daltons to about 85,000 daltons; in the range of about 25,000 daltons to about 120,000 daltons (e.g., each (n) ranges from about 284 to about 1364); 9,000 Daltons to about 120,000 Daltons (e.g., each (n) ranges from about 330 to about 1364); about 35,000 Daltons to about 120,000 Daltons (e.g., each (n) ranges from about 398 to about 1364); about 880 Daltons to about 60,000 Daltons (e.g., each (n) ranges from about 10 to about 682); about 440 Daltons to about 40,000 Daltons (e.g., each (n) ranges from about 5 to about 454); about 44 from about 0 daltons to about 30,000 daltons (e.g., each (n) ranges from about 5 to about 340); from about 10,000 daltons to about 25,000 daltons (e.g., each (n) ranges from about 113 to about 284) or from about 15,000 daltons to about 25,000 daltons (e.g., each (n) ranges from about 170 to about 284), and from about 40,000 daltons to about 120,000 daltons (e.g., each (n) ranges from about 454 to about 1364).For any given water-soluble polymeric reactant, intermediate, reactive carbonate reagent, etc., PEG having a molecular weight in one or more of these ranges is preferred. In some preferred embodiments, the polymeric reagent, intermediate, or reactive carbonate has an overall molecular weight of about 20,000 daltons (POLY. a and POLY b Each of the (n) has a molecular weight of about 10,000 daltons (e.g., each (n) is about 227). In some preferred embodiments, the polymeric starting material (reactant), intermediate, or activated carbonate comprises a C2 core, with each PEG (POLY a and POLY b ) has a molecular weight of about 10,000 daltons. See, for example, illustrative structures XIV (NHS ester), Ih (hydroxyl reactant), and II-h (BTC) or structures corresponding to structures XIV or II-h in which the leaving group of the O-succinimidyl or O-benzotriazolyl group is replaced with another suitable leaving group well known in the art.
[0115] POLY a and POLY bExemplary weight average molecular weights for each of the above are about 100 daltons, about 120 daltons, about 200 daltons, about 250 daltons, about 300 daltons, about 400 daltons, about 440 daltons, about 500 daltons, about 600 daltons, about 700 daltons, about 750 daltons, about 800 daltons, about 900 daltons, about 1,000 daltons, about 1,500 daltons, about 2,000 daltons, about 3,000 daltons, about 4,000 daltons, about 5,000 daltons, about 6,000 daltons, about 7,000 daltons, about 8,000 daltons, about 9,000 daltons, about 10,000 daltons, about 11,000 daltons, about 12,000 daltons, about 13,000 daltons, about 14,000 daltons, about 15,000 daltons, about 16,000 daltons, about 17,000 daltons, about 18,000 daltons, about 19,000 daltons, about 21,000 daltons, about 22,000 daltons, about 23,000 daltons, about 24,000 daltons, about 25,000 daltons, about 26,000 daltons, about 27,000 daltons, about 28,000 daltons, about 29,000 daltons 000 Daltons, about 2,200 Daltons, about 2,500 Daltons, about 3,000 Daltons, about 4,000 Daltons, about 4,400 Daltons, about 4,500 Daltons, about 5,000 Daltons, about 5,500 Daltons, about 6,000 Daltons, about 7,000 Daltons, about 7,500 Daltons, about 8,000 Daltons, about 9,000 Daltons, about 10,000 Daltons, about 1 1,000 daltons, about 12,000 daltons, about 13,000 daltons, about 14,000 daltons, about 15,000 daltons, about 16,000 daltons, about 17,000 daltons, about 18,000 daltons, about 19,000 daltons, about 20,000 daltons, about 22,500 daltons, about 25,000 daltons, about 30,000 daltons, about 35,000 daltons , about 40,000 daltons, about 45,000 daltons, about 50,000 daltons, about 55,000 daltons, about 60,000 daltons, about 65,000 daltons, about 70,000 daltons, and about 75,000 daltons, about 80,000 daltons, about 85,000 daltons, about 90,000 daltons, about 95,000 daltons, and about 100,000 daltons. a and POLY b Exemplary weight average molecular weight ranges for each of POLY are, for example, about 120 daltons to about 100,000 daltons (e.g., each (n) ranges from about 3 to about 2273) or about 250 daltons to about 60,000 daltons (e.g., each (n) ranges from about 4.5 to about 1363). a and POLY bThe weight average molecular weight range for each of is, for example, about 120 daltons to about 6,000 daltons (e.g., each (n) ranges from about 3 to about 136), or about 6,000 daltons to about 80,000 daltons (e.g., each (n) ranges from about 136 to about 1818), or about 5,000 to about 25,000 daltons (e.g., each (n) ranges from about 113 to about 568), or about 10,000 to about 25,000 daltons (e.g., each (n) ranges from about 227 to about 568).
[0116] As described above, POLY a and POLY b Both are preferably polyethylene glycols. When PEG is used as the water-soluble polymer in a polymeric reagent, it typically contains many (OCH2CH2) monomers [or (CH2CH2O) monomers, depending on how PEG is defined]. As used throughout the description, the number of repeating units is referred to as "(OCH2CH2) n ". Thus, the value of (n) typically falls within one or more of the following ranges: 2 to about 3400, about 4 to about 1500, about 100 to about 2300, about 100 to about 2270, about 136 to about 2050, about 225 to about 1930, about 450 to about 1930, about 1200 to about 1930, about 568 to about 2727, about 660 to about 2730, about 795 to about 2730, about 795 to about 2730, about 909 to about 2730, and about 1,200 to about 1,900. For any particular polymer whose molecular weight is known, it is possible to determine the number of repeating units (i.e., "n") by dividing the total weight average molecular weight of the polymer by the molecular weight of the repeating monomer. For example, POLY(R)-(R)-(R)-(R)-(R)-(R)-(R)-(R)-(R)-(R)-(R)-(R)-(R)-(R)-(R) a and POLY b For POLY, which is polyethylene glycol, both have a molecular weight of about 20,000 daltons, the value of (n) is about 227. a and POLY b For,the value of (n) is approximately 454, etc.
[0117] In one or more embodiments, the fluorene moiety optionally includes one or more electron-changing groups ("R e1 ", "R e2 " and the like. Electron changing groups are groups that either donate electrons (hence the term "electron donating groups") or withdraw electrons (hence the term "electron withdrawing groups"). Typical electron withdrawing groups include halo (e.g., bromo, fluoro, chloro, and iodo), nitro, carboxy, ester, formyl, keto, azo, amidocarbonyl, amidosulfonyl, carboxamido, sulfonoxy, sulfonamido, ureido, and aryl. Typical electron donating groups include hydroxyl, lower alkoxy (e.g., methoxy, ethoxy, and the like), lower alkyl (such as methyl, ethyl, and the like), amino, lower alkylamino, di-lower alkylamino, aryloxy (such as phenoxy and the like), arylalkoxy (such as phenoxy and the like), aminoaryl (such as p-dimethylaminophenyl and the like), mercapto, and alkylthio. In one or more embodiments, the fluorene moiety includes one or more halo groups. More specific electron change groups include, but are not limited to, Br, -CF3, -CH2CF3, -CH2C6F5, -CN, -NO2, -S(O)R, -S(O)aryl, -S(O2)R, -S(O2)aryl, -S(O2)OR, -S(O2)Oaryl, -S(O2)NHR, -S(O2)NHaryl, -C(O)R, -C(O)aryl, -C(O)OR, -C(O)NHR, and the like, where R is H or an organic radical. In some embodiments, the electron change group is bromo. R e1 and R e2 If each of R is different, then (a) e1 and R e2 can be different electron withdrawing groups; (b) R e1 and R e2 can be different electron donating groups, (c) or R e1and R e2 can be an electron-withdrawing group and an electron-donating group on one side. However, in many situations, R e1 and R e2 are the same.
[0118] On the fluorene ring, the usual positions for addition of electron changing groups by aromatic electrophilic substitution reactions are the "2" and "7" positions. When these positions are occupied by a linking moiety (attached to a water-soluble polymer), other positions on the fluorene ring may be substituted, based on factors such as (a) the orientation of the linking moiety and (b) steric influences. However, in many cases, the "4" and "5" positions of the fluorene ring are likely sites of attachment when the "2" and "7" positions are unavailable and especially when the alpha carbon, i.e., the 9 position in fluorene (i.e., the carbon bearing an ionizable hydrogen atom, Hα), is substituted. The electron changing group, "R e1 ", "R e2 (if both are present) may be located on the same aromatic ring or on different aromatic rings.
[0119] Water-soluble polymer chain, POLY a and POLY b The linkers, L1 and L2, between the fluorene ring (e.g., polyethylene glycol chains, respectively) and the central fluorene ring can be the same or different. Typically, the linkers, L1 and L2, comprise short chains of atoms or functional groups that may be inserted, for example, during the manufacturing process. These linkers can affect the properties of the releasable polymeric reagent formed, and can affect the release properties of the corresponding polymer conjugate. By manipulating the placement (position of the ring) and the specific structure of the linker, the release rate of the polymer component from the polymer conjugate can be varied, and can be measured, for example, usually over hours or days. Moreover, other independent functional groups, R e1 and / or R e2R is generally, but not necessarily, referred to herein as an electron transfer group, and may be substituted on the aromatic ring to further affect the rate of release of the polymer component from the conjugate. For example, some illustrative R e1 Groups and R e2 Groups include, but are not limited to, halo (e.g., bromo, fluoro, chloro, and iodo), nitro, carboxy, ester, formyl, keto, azo, amidocarbonyl, amidosulfonyl, carboxamido, sulfonoxy, sulfonamido, ureido, and aryl. Exemplary electron donating groups include hydroxyl, lower alkoxy (e.g., methoxy, ethoxy, and the like), lower alkyl (such as methyl, ethyl, and the like), amino, lower alkylamino, di-lower alkylamino, aryloxy (such as phenoxy and the like), arylalkoxy (such as phenoxy and the like), aminoaryl (such as p-dimethylaminophenyl and the like), mercapto, and alkylthio. More specific electron changing groups include, but are not limited to, -CF3, -CH2CF3, -CH2C6F5, -CN, -NO2, -S(O)R, -S(O)aryl, -S(O2)R, -S(O2)aryl, -S(O2)OR, -S(O2)Oaryl, -S(O2)NHR, -S(O2)NHaryl, -C(O)R, -C(O)aryl, -C(O)OR, -C(O)NHR, and the like, where R is H or an organic radical. Thus, for example, L1, L2, and, if present, R e1 and / or R e2 Depending on the structures of and their location on each fluorenyl ring, these types of PEG reagents can be designed that will release drugs over periods of hours or days.
[0120] POLY a and / or POLY band typical linking components inserted between the fluorene components, L1 and L2 are, -C(O)-, -S(O2)-, -S(O)-, -NH-S(O2)-, -S(O2)-NH-, -CH=CH-, -O-CH=CH-, -C(O)-NH-, -NH-C(O)-NH-, -O-C(O)-NH-, -C(S)-, -CH2-, -CH2-CH2-, -CH2-CH2-CH2-, -CH2-CH2-CH2-CH2, -O-CH2-, -CH2-O-, -O-CH2-CH2-, -CH2-O-CH2-, -CH2-CH2-O-, -O-CH2-CH2-CH2-, -CH2-O-CH2-CH2-, -CH2-CH2-O-CH2-, -CH2-CH2-CH2-O-, -O-CH2-CH2-CH2-CH2-, -CH2-O-CH2-CH2-CH2-, -CH2-CH2-O-CH2-CH2-, -CH2-CH2-CH2-O-CH2-, -CH2-CH2-CH2-CH2-O-, -S-CH2-, -CH2-S-, -S-CH2-CH2-, -CH2-S-CH2-, -CH2-CH2-S-, -S-CH2-CH2-CH2-, -CH2-S-CH2-CH2-, -CH2-CH2-S-CH2-, -CH2-CH2-CH2-S-, -S-CH2-CH2-CH2-CH2-, -CH2-S-CH2-CH2-CH2-, -CH2-CH2-S-CH2-CH2-, -CH2-CH2-CH2-S-CH2-, -CH2-CH2-CH2-CH2-S-, -C(O)-NH-CH2-, -C(O)-NH-CH2-CH2-, -CH2-C(O)-NH-CH2-, -CH2-CH2-C(O)-NH-, -C(O)-NH-CH2-CH2-CH2-, -CH2-C(O)-NH-CH2-CH2-, -CH2-CH2-C(O)-NH-CH2-, -CH2-CH2-CH2-C(O)-NH-, -C(O)-NH-CH2-CH2-CH2-CH2-, -CH2-C(O)-NH-CH2-CH2-CH2-, -CH2-CH2-C(O)-NH-CH2-CH2-, -CH2-CH2-CH2-C(O)-NH-CH2-, -CH2-CH2-CH2-C(O)-NH-CH2-CH2-, -CH2-CH2-CH2-CH2-C(O)-NH-, -NH-C(O)-CH2-C(O)-NH-, -NH-C(O)-CH2-CH2-C(O)-NH--NH-C(O)-CH2-CH2-CH2-C(O)-NH-, -NH-C(O)-CH2-CH2-CH2-CH2-C(O)-NH-, -NH-C(O)-CH=CH-C(O) -NH-, -C(O)-O-CH2-, -CH2-C(O)-O-CH2-, -CH2-CH2-C(O)-O-CH2-, -C(O)-O-CH2-CH2-, -NH-C(O)-C H2-, -CH2-NH-C(O)-CH2-, -CH2-CH2-NH-C(O)-CH2-, -NH-C(O)-CH2-CH2-, -CH2-NH-C(O)-CH2-CH2- , -CH2-CH2-NH-C(O)-CH2-CH2-, -C(O)-NH-CH2-, -C(O)-NH-CH2-CH2-, -OC(O)-NH-CH2-, -OC(O)-NH- CH2-CH2-, -NH-CH2-, -NH-CH2-CH2-, -CH2-NH-CH2-, -CH2-CH2-NH-CH2-, -C(O)-CH2-, -C(O)-CH2-C H2-, -CH2-C(O)-CH2-, -CH2-CH2-C(O)-CH2-, -CH2-CH2-C(O)-CH2-CH2-, -CH2-CH2-C(O)-, -CH2-CH2 -CH2-C(O)-NH-CH2-CH2-NH-, -CH2-CH2-CH2-C(O)-NH-CH2-CH2-NH-C(O)-, -CH2-CH2-CH2-C(O)-NH -CH2-CH2-NH-C(O)-CH2-, -CH2-CH2-CH2-C(O)-NH-CH2-CH2-NH-C(O)-CH2-CH2-, -OC(O)-NH-[CH2], h -(OCH2CH2) j -, -NH-C(O)-O-[CH2] h -(OCH2CH2) j -, divalent cycloalkyl group, O, S, amino acid, -N(R 6 )-, and combinations of any two or more of the foregoing, where R 6 is H or an organic radical selected from the group consisting of alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, and substituted aryl, (h) is 0 to 6, and (j) is 0 to 20. Another specific linking moiety has the structure: -C(O)-NH-(CH2)1~6 -NH-C(O)-, -NH-C(O)-NH-(CH2) 1~6 -NH-C(O)- and -OC(O)-NH-(CH2) 1~6 -NH-C(O)-, where the value of the subscript after each methylene indicates the number of methylenes contained in the structure, e.g., (CH2) 1~6 means that the structure can contain 1, 2, 3, 4, 5, or 6 methylenes. Moreover, any of the above linking moieties may further include an ethylene oxide oligomer chain containing 1-20 ethylene oxide monomer units (i.e., --(CH2CHO)1-20). That is, the ethylene oxide oligomer chain may occur before or after the linking moiety and, optionally, between any two atoms of a linking moiety composed of two or more atoms. Furthermore, an oligomer chain would not be considered part of the linking moiety if the oligomer is adjacent to the polymer segment and is merely an extension of the polymer segment. Finally, it is noted that some linking moieties include an atom or group of atoms that also functions as an electron changing group; in such cases, the inclusion of one or more other "separate" (i.e., not part of the linking moiety) electron changing groups may not be desired or necessary.
[0121] L1 and L2 are the preferred bonding components は、-C(O)-NH-CH2-CH2-、-CH2-CH2-NH-C(O)-、-C(O)-NH-CH2-CH2-CH2-、-CH2-CH2-CH2-NH-C(O)-、-C(O )-NH-CH2-CH2-CH2-CH2-、-CH2-CH2-CH2-CH2-NH-C(O)-、-C(O)-NH-、-NH-C(O)-、-C(O)-NH-CH2-CH2-CH2-CH2-CH2-、-CH2-CH2 -CH2-CH2-CH2-NH-C(O)-、-NH-C(O)-CH2-CH2-、-CH2-CH2-C(O)-NH-、-NH-C(O)-CH2-CH2-CH2-、-CH2-CH2-CH2-C(O)-NH-、-NH- C(O)-CH2-CH2-CH2-CH2-、-CH2-CH2-CH2-CH2-C(O)-NH-、-NH-C(O)-CH2-CH2-CH2-CH2-CH2-、-CH2-CH2-CH2-CH2-CH2-C(O)-NH -、-NH-C(O)-CH2-CH2-C(O)-、-C(O)-CH2-CH2-C(O)-NH-、-NH-C(O)-CH2-CH2-CH2-C(O)-、-C(O)-CH2-CH2-CH2-C(O)-NH-、-NH -C(O)-CH2-CH2-CH2-CH2-C(O)-、-C(O)-CH2-CH2-CH2-CH2-C(O)-NH-、-NH-C(O)-CH2-CH2-CH2-CH2-CH2-C(O)-、-C(O)-CH2-CH 2-CH2-CH2-CH2-C(O)-NH-、-C(O)-CH2-CH2-、-CH2-CH2-C(O)-、-C(O)-CH2-CH2-CH2-、-CH2-CH2-CH2-C(O)-、-C(O)-CH2-CH2-C H2-CH2-、-CH2-CH2-CH2-CH2-C(O)-、-C(O)-CH2-CH2-CH2-CH2-CH2-、-CH2-CH2-CH2-CH2-CH2-C(O)-、-NH-CH2-CH2-(OCH2CH2) 1~3 -NH-C(O)-、-C(O)-NH-(CH2CH2O) 1~3 -CH2-CH2-NH-、-C(O)-NH-CH2-CH2-(OCH2CH2) 1~3 -NH-C(O)-、-C(O)-NH-(CH2CH2O) 1~3-CH2-CH2-NH-C(O)-, -NH-C(O)-CH2-, -CH2-C(O)-NH-, -NH-C(O)-CH2-O-, -O-CH2-C(O)-NH-, -CH 2-CH2-NH-C(O)-CH2-CH2-CH2-C(O)-NH-, -NH-C(O)-CH2-CH2-CH2-C(O)-NH-CH2-CH2-, -O-CH2-C Includes those selected from H2-NH-C(O)-CH2-CH2-CH2-C(O)-NH-, -NH-C(O)-CH2-CH2-CH2-C(O)-NH-CH2-CH2-O-, -C(O)-NH-CH2-CH2-, -CH2-CH2-NH-C(O)-, -C(O)-NH-CH2-CH2-, -CH2-CH2-NH-C(O)-, -C(O)-NH-CH2-CH2-O-, and -O-CH2-CH2-NH-C(O)-.
[0122] Each connected component, if present, in the overall structure can be the same or different from any other connected component in the overall structure. 1 and L 2 Regarding L 1 and L 2 However, it is sometimes preferable for them to be the same.
[0123] Preferred linking moieties include amidocarboxy, carboxamide, sulfonamide, ester, and ureido. More specific linking moieties include, for example, -(CH2) 1~6 C(O)NH- and -NH-C(O), NH-C(O)-(CH2) 1~6 More specific linking moieties are, for example, selected from -(CH2)C(O)NH-, -(CH2)3C(O)NH-, -NH-C(O), and NH-C(O)-(CH2)3C(O)NH-.
[0124] Connected component, L 1 and L 2 and thus the water-soluble polymer "arm", POLY a and POLY b may likewise be located at any two convenient positions on the fluorene ring, for example at carbons 1, 2, 3, 4, 5, 6, 7, or 8. In some embodiments, L 1 and L2 is attached to the fluorene carbons C-2 and C-7. 1 and L 2 is attached to the fluorene carbons C-2 and C-5. See, for example, illustrative structures XI, XIII, Id, If, Ig, II-d, II-f, and II-g (at C-2 and C-5 positions) and structures XII, XIV, Ie, Ih, II-e, and II-h (at C-2 and C-7 positions).
[0125] The examples which follow illustrate improved methods (i) for preparing fluorenyl-based polymeric reagents, (ii) for recovering and purifying such reagents, (iii) for reducing undesirable impurities in the fluorenyl-based polymeric reagents, (iv) for avoiding the use of hazardous and potentially explosive reactants such as phosgene and DiBTC, respectively, and (v) for converting, among other things, non-succinimidyl fluorenyl-based polymeric esters to desired NHS-esters.
[0126] All papers, books, patents, patent publications, and other publications referred to in this specification are incorporated by reference in their entirety. In the event of any discrepancy between the teachings of this specification and the technology incorporated by reference, the teachings and definitions explained in this specification shall prevail (especially with respect to the terms used in the claims attached hereto). For example, if this application and the publication incorporated by reference define the same term differently, the definition of the term shall remain within the teachings of the text in which the definition is written. EXAMPLES
[0127] It should be understood that the foregoing description and the following examples are intended to illustrate the invention provided herein and not to limit the scope thereof. Other aspects, advantages, and modifications within the scope of the invention will be apparent to those skilled in the art.
[0128] Materials and Methods The present disclosure employs, unless otherwise indicated, conventional techniques of organic synthesis and the like, as understood by those of skill in the art and described in the literature. In the following examples, efforts have been made to ensure accuracy with respect to numbers used (e.g., amounts, temperatures, etc.), but some experimental error and deviation should be accounted for. Unless otherwise indicated, temperatures are in degrees Celsius and pressures are at or near sea level pressure.
[0129] All radiochemical processes and analyses for radiolabeled polymers ( 1 H and 3 H-NMR, specific activity, molecular weight using GFC equipped with both RI and UV detectors) were performed at Moravek Biochemicals, Inc., Los Angeles, CA, and were supervised and witnessed by one of the inventors.
[0130] With the exception of the PEG reagent, all reagents were obtained commercially unless otherwise noted. All PEG raw materials were purchased from Nektar Therapeutics, Huntsville, AL. All NMR data generated at Nektar Therapeutics was obtained using 300 or 400 MHz NMR systems manufactured by Bruker (Billerica, MA). Reactions involving PEG derivatives were carried out in glass or glass-lined vessels.
[0131] Safety Warning: Before performing procedures using reagents that have safety or hazard warnings, laboratory personnel should become familiar with safe handling procedures to avoid serious accidents. In particular, dibenzotriazolyl carbonate (di-BTC) is an explosive hazard under certain conditions. These procedures should only be performed by experienced chemists or highly trained technicians.
[0132] Abbreviation: ACN Acetonitrile anh anhydrous BHT Butyl hydroxytoluene di-BTC Dibenzotriazolyl carbonate DCM Dichloromethane DCC N,N'-dicyclohexylcarbodiimide DMAP 4-Dimethylaminopyridine DMF Dimethylformamide EDAC HCl 1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide, HCl HOBT Hydroxybenzotriazole IPA Isopropyl Alcohol MTBE Methyl tert-butyl ether NHS N-hydroxysuccinimide Pyr Pyridine RB round bottom RT Room temperature, 20~25℃ THF Tetrahydrofuran
[0133] Example 1 Synthesis of illustrative G2-PEG2-FMOC-NHS reagents Scheme E1 - Illustration of a typical reaction for the synthesis of G2-PEG2-FMOC-NHS reagent via benzotriazole carbonate [ka] A. Preparation of G2-PEG2-FMOC-OH 20K mPEG-NH2 (10,000 Da) (25.1 g, 2.51 mmol) dissolved in anhydrous toluene (250 mL) was azeotropically dried by distilling toluene under reduced pressure at 45° C. on a rotary evaporator. The solid residue was dissolved in anhydrous dichloromethane (DCM) (125 mL) under nitrogen atmosphere. A solution of G2-FMOC-core (9-hydroxymethyl-2,7-di(amido glutaric acid) fluorene) (0.5211 g, 1.15 mmol) and anhydrous N-hydroxybenzotriazole (HOBt) (0.3251 g, 2.41 mmol) dissolved in anhydrous DMF (12.7 mL) was added to the mPEG-NH2 solution. 1,3-Dicyclohexylcarbodiimide (DCC) (0.645 g, 3.13 mmol) was then added to the solution. The reaction mixture was stirred at room temperature for 17 hours. The solvent was then distilled under reduced pressure. The thick syrup was dissolved in anhydrous isopropyl alcohol (IPA) (300 mL, added slowly) with moderate heating. The PEG product was precipitated by addition of diethyl ether (200 mL) at room temperature. The precipitate was cooled to 10° C. for 20 min, filtered, and washed with IPA (300 mL) and then diethyl ether (500 mL×3). The crude product was dried under vacuum, resulting in 25 g of off-white powder.
[0134] The crude material was dissolved in deionized water (500 mL) and diluted to a total volume of 1300 ml. The pH of the solution was adjusted to 9.7 with 1 M NaOH. Chromatographic removal of unreacted mPEG-NH2 (10,000) was carried out with POROS HS50 medium (500 mL) using water as eluent. The fractions containing the PEG product were collected and further purified by passing through DEAE Sepharose FF medium (200 mL). The purified product was found to contain neither mPEG-NH2 (10,000) nor mono-PEG acid product (HPLC analysis).
[0135] A small amount of diethylenetriaminepentaacetic acid (DTPA) and sodium chloride (170 g) was added and the pH was adjusted to 7.56 with 1M NaOH. The product was extracted from the aqueous layer with DCM (250, 250, 100 mL). The DCM extract was dried with sodium sulfate, filtered, and isolated with IPA and diethyl ether. The purified product was dried under vacuum (yield 20.95 g, off-white powder). GPC analysis showed 99% of the desired G2-PEG2-FMOC-OH 20K. 1 H-NMR(CD2Cl2):δ(ppm):8.6 (s,NH,2H); 7.9(s,Ar,2H);7.6(m,Ar,4H); 6.4(bs,NH,2H); 4.1(m,CH,1H);4.0(d,CH 2, 2H)3.6(bs,PEG skeleton);3.3(s,OCH3,6H);2.4(t,CH2,4H);2.3(t,CH2,4H);2.0(m,CH2,4H).
[0136] B. Preparation of G2-PEG2-FMOC-BTC 20K G2-PEG2-FMOC-OH 20K (1.8 g, 0.28 mmol) was dissolved in DCM (5 mL) and anhydrous toluene (20 mL) was added. The solvent was then distilled to dryness to remove water and the dried material was dissolved in 5.4 mL of anhydrous acetonitrile. To this solution was added dibenzotriazolyl carbonate (di-BTC) (77 mg) and anhydrous pyridine (7.3 μL). The solution was stirred at RT for 2 h 15 min and then anh IPA (200 mL containing 50 ppm BHT) was added to precipitate the product. After 15 min, the solution was filtered and the solid was washed with anh IPA (45 mL containing 50 ppm BHT) and then with diethyl ether (4×50 mL containing 100 ppm BHT). The product was dried under vacuum overnight. Yield 1.49 g. 1H-NMR(DMSO-d6):δ(ppm)8.6(s,NH,2H);8.0(s,Ar,2H);7.6(m,Ar,4H);6.4(bs,NH,2H);5.0(m,CH2-BTC, 2H);4.5(t,CH,1H);)3.6(s,PEG skeleton);3.3(s,OCH3,6H);2.4(t,CH2,4H);2.3(t,CH2,4H);2.0(m,CH2,4H).
[0137] C. Preparation of G2-PEG2-FMOC-NHS 20K G2-PEG2-FMOC-BTC 20K (1.47 g) was dissolved in anh DCM (5.9 mL) and the solution was cooled to 8° C. NHS (170.6 mg) was added and the mixture was stirred at 8° C. overnight. The product was precipitated by addition of IPA (60 mL containing 293 mg citric acid and 10 mg BHT), filtered and washed with anh IPA (60 mL containing 10 mg BHT) and then with anh methyl tert-butyl ether (MTBE) (50 mL containing 35 mg citric acid and 8.2 mg BHT). The product was then dried under vacuum overnight. Yield 1.27 g. 1 H-NMR(DMSO-d6):δ(ppm)8.6(s,NH,2H);7.8(s,Ar,1H);7.7(s,Ar,2H);7.6(m,Ar,4H);6.4(bs,NH,2H);4.6(d,CH2,2H) );4.3(t,CH,1H),3.6(bs,PEG backbone);3.3(s,OCH3,6H);2.8(s,NHS,4H);2.4(t,CH2,4H);2.3(t,CH2,4H);2.0(m,CH2,4H).
[0138] The product end group substitution percentage of the activated carbonate was determined by reaction with glycine followed by HPLC analysis of the conjugate and showed 88.1 mol%. After 136 hours of storage at 11°C, analysis with glycine substitution showed a substitution percentage of 86.6 mol%. A similar product precipitated without the addition of citric acid to IPA and no citric acid present in the wash with MTBE had a substitution of 86.2 mol% after preparation and 75.3 mol% after 136 hours of storage at 11°C. The G2-PEG2-FMOC-glycine conjugate was prepared as follows: G2-PEG2-FMOC-NHS 20K (10 mg)) was dissolved in 1 mL of 5% glycine buffer (pH 7.4). The resulting solution was mixed well and allowed to react at room temperature for 10 minutes. The analysis was carried out by injecting samples of the solutions for GFC analysis (Waters; Ultrahydrogel250; 10 mM HEPES buffer pH 7.4, 75°C).
[0139] Example 2 Synthesis of brominated G2-PEG2-FMOC-NHS 20K (BR-G2-PEG2-FMOC-NHS 20K) [ka] Scheme E2. Synthesis of brominated G2 reagent (Br-G2-PEG2-FMOC-NHS 20K). A. Preparation of brominated G2-FMOC core (9-hydroxymethyl-bromo-2,7-di(amidoglutaric acid)fluorene) 9-Hydroxymethyl-2,7-di(amido glutaric acid) fluorene (1.5 g, 3.3 mmol) was dissolved in 1,4-dioxane (45 mL) and deionized water (30 mL). Pyridinium bromide perbromide (vinyl pyridine polymer bound, ca. 2 mmol Br3 / g resin, 25 g) was added and stirred in the dark for 2 h. The reaction suspension was filtered and washed with 1,4-dioxane / water (20 mL) followed by 1,4-dioxane (20 mL). The product was extracted with half-saturated sodium chloride and ethyl acetate (400 mL x 2). The organic extract was dried over anhydrous sodium sulfate, filtered and the solvent was distilled under reduced pressure. The resulting crude product was purified by C18 silica chromatography using 50 mM ammonium acetate (pH 4.75) and methanol gradient elution to give 0.4 g of off-white powder. 1 H-NMR(DMSO-d6):δ(ppm)8.1(s, Ar,1H);7.9(s,Ar,1H);7.8(m,Ar,2H);7.6(d,Ar,1H);4.0(t,CH,1H);3.7(m,CH2,2H,);2.4(m,CH2,4H);2.2(m,CH2,4H);1.8(m,CH2,4H).
[0140] B. Preparation of brominated G2-PEG2-FMOC-OH (9-hydroxymethyl-bromo-2,7-di(mPEG(10K)-amido glutaramide)fluorene) mPEG-NH2 (10,000 Da) (14 g, 1.42 mmol) dissolved in anhydrous toluene (250 mL) was azeotropically dried by distilling off the solvent under reduced pressure at 50° C. on a rotary evaporator. The solid residue was dissolved in anh DCM (130 mL) under nitrogen atmosphere. A solution of brominated G2-FMOC-OH (0.315 g, 0.59 mol) and anh N-hydroxybenzotriazole (HOBt) (0.17 g, 1.24 mmol) in anh DMF (8 mL) was added to the PEG-NH2 solution. 1,3-Dicyclohexylcarbodiimide (DCC) (0.34 g, 1.65 mmol) was then added. The mixture was stirred at room temperature for 21 hours and the solvent was then distilled off under reduced pressure. The thick syrup was dissolved in anh IPA (500 mL, added slowly) with moderate heating. The PEG product was precipitated by the addition of diethyl ether (200 mL) at room temperature. The precipitate was cooled to 10° C. for 10 min, filtered, washed with cold IPA (150 mL) and with diethyl ether (150 mL), and then it was dried under vacuum to give 13.2 g of an off-white powder.
[0141] The dried crude product was dissolved in deionized water (850 mL) and the pH was adjusted to pH 9.7 with 1 M NaOH. Chromatographic removal of unreacted mPEG-NH2 (10,000 Da) was carried out with POROS HS50 medium (500 mL) using water as eluent. The fractions containing the PEG product were collected and further purified with DEAE Sepharose medium (200 mL). GPC analysis showed 93% of the desired brominated G2-PEG2-FMOC-OH product. 1 H-NMR(CD2Cl2):δ(ppm)8.8(s,NH);8.5(s,NH);7.9(s,Ar,2H);7.8(s,Ar);7.7(m,Ar);7.6(m,Ar);6.6( bs,NH);6.4(bs,NH);4.1(m,CH2);3.6(bs,PEG backbone);3.4(s,OCH3);2.6(t,CH2);2.5(t,CH2);2.3(m,CH2).
[0142] C. Preparation of Brominated G2-PEG2-FMOC-BTC Brominated G2-PEG2-FMOC-OH (5.6 g, 0.28 mmol) dissolved in toluene (55 mL) was azeotropically dried at 50° C. by distilling the solvent and dissolved in 10 mL of anhydrous acetonitrile. Then di-BTC (0.33 g, 0.50 mmol) and anhydrous pyridine (22.5 μL, 0.28 mmol) were added. The solution was stirred at room temperature for 3 h, then the product was precipitated with IPA (250 mL) and filtered. The filtrate was washed with IPA (100 mL) and with diethyl ether (100 mL) and then dried in vacuum at rt for 2 h. The obtained brominated G2-PEG2-FMOC-BTC was used in the next step of the synthesis without further purification. 1 H-NMR(CDCl3):δ(ppm)9.0(s,NH);8.6(s,NH);8.1-7.5(m,Ar);6.9(bs,NH);6.8(bs,NH);4. 9(d,CH2);4.4(t,CH);3.6(bs,PEG backbone);3.4(s,OCH3);2.5(t,CH2);2.3(t,CH2);2.0(m,CH2).
[0143] D. Preparation of brominated G2-PEG2-FMOC-NHS (Br-G2-PEG2-FMOC-NHS 20K) Brominated G2-PEG2-FMOC-BTC (4.71 g. 0.235 mmol) was dissolved in DCM (18.8 mL) and N-hydroxysuccinimide (NHS) (0.542 g, 4.71 mmol) was added. The reaction mixture was stirred for 22 h and then added to IPA (200 mL) containing 0.5% acetic acid. The precipitated product was filtered and washed with 20 mL of IPA (20 mL) containing 0.5% acetic acid and then with diethyl ether (60 mL) containing 0.5% acetic acid. The wet product was dried in vacuum for 2 h and then reprecipitated by dissolving in anh acetonitrile (14.1 mL) followed by the addition of IPA (235 mL) containing 0.5% acetic acid. The precipitate was filtered, washed with diethyl ether (60 mL) containing 0.5% acetic acid and 0.005% BHT and dried overnight in vacuum at rt. Yield: 4.2 g. 87 mol % substitution of active NHS ester groups. 20K. GFC analysis showed the presence of 93.3% 20K PEG product and 6.4% 10K PEG product. 1 H-NMR(CD2Cl2)δ(ppm):8.8 and 8.5(s,s,NH);8.0-7.5(m,Ar);6.6 and 6.4(s,s,NH);4.7,4.6(m,CH2);4.3(m,CH);3.6(bs,PEG backbone);3.4(s,OCH3);2.8(s,NHS);2.5(t,CH2);2.3(t,CH2)2.0(m,CH2).
[0144] Example 3 Methods for the synthesis of C2-PEG2-FMOC-NHS 20K Part 1. Synthesis of 9-hydroxymethyl-2,7-fluorenedicarboxylic acid (C2-FMOC core), see Scheme E3a. [ka] Scheme E3a Synthesis of C2-FMOC core A. Preparation of 2,7-fluorenedicarboxylic acid In an argon purged flask, 9-fluorenone-2,7-dicarboxylic acid (10.0 g, 0.037 mol) was suspended in diethylene glycol (75 mL). The flask was placed in a room temperature oil bath, and then 80% solutions of NaOH (6.2 g, 0.155 mol) and hydrazine hydrate (7.4 mL, 0.12 mol) were added in sequence. The reaction mixture was slowly heated to 110° C. and then refluxed for approximately 4 hours. The reaction mixture was cooled, carefully poured into water, and acidified to pH 2 with concentrated HCl. The precipitated crude product was filtered and washed with water, which was then dissolved in warm NaOH solution (0.5 M) and reprecipitated by acidification to pH 2 with HCl. The precipitate was filtered and washed with water to give a solid yellow product (9.0 g, 96%). 1 H-NMR(DMSO- d6):δ(ppm)8.2(s,Ar,2H);8.1(m,Ar,2H);8.0(m,Ar,2H);4.1(s,2H,CH2).
[0145] B. Preparation of 2,7-fluorenedicarboxylic acid dibenzyl ester In a dry flask purged with nitrogen, 2,7-fluorenedicarboxylic acid (8.0 g, 0.031 mol) was dissolved in anh DMF (400 mL). Then, anh benzyl alcohol (82 mL, 0.788 mol), DMAP (0.58 g, 0.0047 mol), and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDAC) hydrochloride (16 g, 0.082 mol) were added at rt. After stirring for 24 h, dilute HCl solution (1.5 L) was added. The mixture was cooled and the solid precipitate was filtered and washed with water. The product was then dissolved in warm acetone (800 mL), the solution was filtered, and the solvent was distilled under reduced pressure. (Yield 5.9 g, 43%). 1 H-NMR (DMSO-d6): δ(ppm)8.3(s,Ar,2H);8.2(m,Ar,2H);8.1(m,Ar,2H);7.5-7.4(m,BnO,10H);5.4(s,CH2,4H);4.1(s,Ar,2H).
[0146] C. Preparation of 9-formyl-2,7-fluorenedicarboxylic acid dibenzyl ester In a flask purged with dry argon, 2,7-fluorenedicarboxylic acid dibenzyl ester (3.0 g, 0.0065 mol) was dissolved in anh THF (60 mL) at room temperature. Benzyl formate (4.2 mL, 0.035 mol, stored over anh K2CO3) was added, followed by potassium tert-butoxide 95% (2.7 g, 0.023 mol). The mixture was stirred for 3 hours, then the reaction was quenched by addition of water and acidified to pH 2 with HCl. The organic solvent was partially evaporated under reduced pressure. The product was extracted twice with ethyl acetate (600 mL, then 200 mL). The combined organic layers were washed three times with brine, dried over sodium sulfate, filtered, and the solvent was evaporated to dryness. The crude product was washed with hexane and methanol and then dried. Yield 1.9 g (60%). 1 H-NMR(DMSO- d6):δ(ppm)11.9(s,formyl,~1H);8.8(s,Ar,1H);8.5(s,Ar,1H);8.4(s,Ar,1H);8.2(m,Ar,2H);7.9(m,Ar,2H);7.5-7.4(m,BnO,10H);5.4(s,Ar,4H).
[0147] D. Preparation of 9-formyl-2,7-fluorenedicarboxylic acid In a Parr hydrogenation bottle, 9-formyl-2,7-fluorenedicarboxylic acid dibenzyl ester (3.0 g, 0.0061 mol) was dissolved in anh THF (350 mL). 20% Pd / C (50% aqueous; 600 mg) was then added and the Parr bottle was evacuated / filled three times with a Parr apparatus to ensure a hydrogen atmosphere. The suspension was shaken under 20-30 psi of hydrogen for approximately 60 hours, then the remaining hydrogen was removed under reduced pressure. The solution was filtered through a pad of Celite and the solvent was distilled under reduced pressure. 1 H-NMR (DMSO-d6): δ(ppm)9.0(s,Ar,1H);8.5-8.1(m,Ar,6H).
[0148] E. Preparation of 9-hydroxymethyl-2,7-fluorenedicarboxylic acid (C2 FMOC core or C2-FMOC-OH) A small sample (5-10 mg) of 9-formyl-2,7-fluorenedicarboxylic acid was dissolved in water containing a small amount of THF. Excess sodium borohydride was added and allowed to react for 2 hours. The reaction was quenched by careful addition of 1M HCl. The product was extracted with ethyl acetate, dried over sodium sulfate, filtered, and the solvent was evaporated under reduced pressure to dryness. 1 H-NMR (CD3OD): δ (ppm) 8.4 (s, Ar, 2H); 8.2 (m, Ar, 2H); 8.0 (m, Ar, 2H); 4.2 (t, CH, 1H); 4.0 (d, CH2, 2H). Large-scale versions of this reaction typically yielded 80-85% pure product. Purification using Biotage column chromatography yielded C2-FMOC-OH at purity levels of 98-99%.
[0149] Part 2. Methods for the synthesis of PEG2-C2-FMOC-NHS from the C2-FMOC core, see Schemes E3b and E3c. [ka] Scheme E3b Synthesis of C2-PEG2-FMOC-NHS via C2-PEG2-FMOC-BTC 20K I. Synthesis of C2-PEG2-FMOC-NHS via C2-PEG2-FMOC-BTC 20K A. Preparation of C2-PEG2-FMOC-OH 20kDa. mPEG-NH2 (Mn=10 kDa; 12.0 g) was dissolved in anh DCM (10 mL) at 25° C. In a separate Biotage flask, purified C2-FMOC-OH (0.165 g) and N-hydroxybenzotriazole hydrate (0.232 g) were dissolved in anh DMF (5.5 mL) and the resulting solution was added to the mPEG-NH2 solution. A 1.0 M solution of DCC in DCM (1.53 mL) was then added and the reaction mixture was stirred at 25° C. for 10 h. The crude product was isolated by precipitation with a mixture of IPA (120 mL) and MTBE (350 mL). The precipitate was filtered, rinsed with IPA (60 mL), twice with MTBE (60 mL and 130 mL) and dried under vacuum. The product was then dissolved in 560 ml of deionized water and the pH of the solution was adjusted to pH 9.7 with 0.2 M NaOH. Removal of unreacted mPEG-NH2 by ion exchange chromatography was carried out with POROS HS50 medium (80 mL) using water as eluent. The fractions containing the PEG product were collected and further filtered through DEAE Sepharose FF medium (40 mL). Sodium chloride (96 g) was added to the DEAE purified eluent and the pH of the solution was adjusted to 7.5 with 1 M NaOH. C2-PEG2-FMOC-OH 20K was extracted from the aqueous layer with DCM (120 mL). The DCM extract was dried (Na2SO4) and the product was precipitated with an IPA / MTBE mixture, filtered and dried under vacuum. Yield: 11.5 g of white solid product. 1 H-NMR(CDCl3):δ(ppm)8.2(s,Ar,2H);7.9(d,Ar,2H);7.8(d,Ar,2H);4.2(t,CH,1H);4.0(d,CH2,2H);3.6(bs,PEG backbone);3.4(s,OCH3,6H).
[0150] B. Preparation of C2-PEG2-FMOC-BTC 20K C2-PEG2-FMOC-OH 20K (11.0 g) dissolved in anh toluene (110 mL) was azeotropically dried by distilling off the solvent under reduced pressure. Toluene was added once more and distilled to dryness in vacuum, and the residue was dissolved in anh acetonitrile (33 mL). The resulting solution was cooled to 5° C. and di-BTC (0.50 g) and anh pyridine (56 μl) were added. The mixture was stirred at 4-6° C. for 6 h 40 min, then it was slowly added to IPA (275 mL) containing 0.005% phosphoric acid cooled to 5° C. After mixing for 0.5 h, MTBE (275 mL) containing 0.005% phosphoric acid cooled to 5° C. was added and the mixture was stirred for 30 min to precipitate the product. The product was filtered and then washed twice with a 1:1 mixture of IPA / MTBE (275 mL) containing 0.005% phosphoric acid, followed by a second two washes with a 1:1 mixture of IPA / MTBE (275 mL) containing 0.002% phosphoric acid. The resulting product, C2-PEG2-FMOC-BTC 20K, was dried under vacuum at 15° C. Yield 10.5 g 1 H-NMR(CDCl3):δ(ppm)8.3(s,Ar,2H);8.0(d,Ar,2H);7.9(d,Ar,2H);7.8(d,benzotriazole,1H);7.6(d,benzotriazole,1H);7 .4(t,benzotriazole,1H);7.1(t,benzotriazole,1H);4.8(m,CH2-BTC,2H);4.5(t,CH,1H);3.6(bs,PEG backbone);3.4(s,OCH3,6H).
[0151] C. Preparation of C2-PEG2-FMOC-NHS 20K from C2-PEG2-FMOC-BTC 20K C2-PEG2-FMOC-BTC (10.0 g) was dissolved in anh DCM (40 mL). With stirring, solid NHS (0.60 g) was added and mixed for a minimum of 15 min while maintaining the temperature at -5 to -10 °C. An equal amount of anhydrous DMAP (0.030 g) was added while maintaining the reaction temperature constant, and the reaction mixture was stirred for 20 h until NMR analysis showed that C2-PEG2-FMOC-BTC was converted to the NHS product. The mixture was then added to IPA (250 mL) containing trifluoroacetic acid (TFA) (0.30 mL) at a temperature of -5 °C. Cold MTBE (250 mL) was added and the precipitated product was filtered and washed with a cold 1:1 mixture of IPA / MTBE (250 mL) containing 0.01% TFA. The washing step was repeated and the precipitate was further washed with a cold 1:1 mixture of IPA / MTBE (500 mL) containing 0.01% phosphoric acid, followed by a second wash with cold MTBE (250 mL) containing 0.01% phosphoric acid. The wet product, C2-PEG2-FMOC-NHS 20K, was dried under vacuum overnight. Yield 9.5 g. 1 H NMR(CDCl3):δ(ppm)8.1(s,Ar,2H);8.0(d,Ar,2H);7.9(d,Ar,2H);4.7(d,CH2,2H);4.5(t,CH,1H);3.6(bs,PEG backbone);3.4(s,OCH3,6H);2.9(s,NHS).
[0152] II. Direct synthesis of C2-PEG2-FMOC-NHS 20K from C2-PEG2-FMOC-OH 20K [ka] Scheme E3c: Synthesis of C2-PEG2-FMOC-NHS directly from C2-PEG2-FMOC-OH 20K C2-PEG2-FMOC-OH 20K (5.0 g) dissolved in 100 ml of anh DCM was azeotropically dried by distilling off the solvent under reduced pressure. The drying process was repeated and the residue was dissolved in anh DCM (25 mL). Disuccinimidyl carbonate (DSC) (0.130 g, 2.0 equiv.) was added while maintaining the bath temperature at approximately 15° C., while maintaining an inert atmosphere (dry nitrogen) throughout the process. The temperature was reduced to 10° C., pyridine (0.101 mL, 5.0 equiv.) was added, and the mixture was stirred at 8-10° C. for 20 hours. It was then cooled to 5° C., TFA (0.19 mL, 10 equiv.) was added, and stirring was continued for approximately 0.3 hours. The solution was filtered through a 0.2 micron filter and added to 100 ml of cold IPA (100 mL) containing 0.1% TFA at 5° C. The mixture was stirred for about 3.0 h, then cold MTBE (100 mL) containing 0.1% TFA was added. The precipitated product was filtered, washed with MTBE (200 mL and 100 mL containing 0.1% phosphoric acid) and dried under vacuum for 12 h. 1 H-NMR(CDCl3):δ(ppm)8.1(s,Ar,2H);8.0(d,Ar,2H);7.9(d,Ar,2H);4.7(d,CH2,2H);4.5(t,H,CH);3.6(bs,PEG backbone);3.4(s,OCH3,6H);2.9(s,NHS).
[0153] Example 4 Tritium exchange 3 Methods for the synthesis of H-G2-PEG2-FMOC-NHS 20K Tritium exchange of G2-PEG2-FMOC-OH 20K G2-PEG2-FMOC-OH 20K (1.2 g) from Example 1 was dissolved in 7.2 ml of phosphate buffer pH 8.5 and palladium hydroxide on activated carbon (0.42 g, 20% Pd content (dry basis), 52% water wet) was added. The suspension was sparged with argon for 30 min and then frozen with liquid nitrogen. The frozen solution was then exposed to tritium gas, warmed to rt, and then blanketed with tritium for 4.5 h. Tritium gas was pumped out of the vessel and approximately 50 ml of DI water was added. The solution was filtered to remove the palladium catalyst. Water was distilled in vacuum at ambient temperature to remove the remaining tritium gas and then redissolved in 20 ml DI water. The labeled PEG was stored as a frozen aqueous solution overnight. After thawing the sample at rt, sodium chloride (8.5 g) was added and the pH was adjusted to pH 7.1 with dilute phosphoric acid. The labeled PEG was then extracted with DCM (3×20 mL), dried over sodium sulfate (9 g) and filtered. The DCM was evaporated under argon. The PEG was dissolved in DCM (5 mL) and anh toluene (20 mL) and the solvent was evaporated under argon. 3 The yield of H-G2-PEG2-FMOC-OH 20K (9) was 0.96 g. 1 H-NMR(CD2Cl2):δ(ppm)8.8,8.7(s,s,NH);7.9(d,Ar);7.6-7.4(m,Ar);6.5(bs,NH); 4.0(m,CH,CH2);3.6(s,PEG backbone);3.3(s,OCH3);2.4(t,CH2);2.3(t,CH2);2.0(m,CH2).
[0154] Activated Carbonate 3 Preparation of H-G2-PEG2-FMOC-NHS 20K 3H-G2-PEG2-FMOC-OH 20K (0.96 g) was dissolved in anh acetonitrile (3 mL). Di-BTC) (67 wt% slurry in trichloroethane, 48 mg) and anh pyridine (4 μl) were added and the reaction mixture was stirred for 2 h. The product was precipitated with IPA (50 mL, containing 50 ppm BHT), cooled on ice, filtered, washed with IPA (50 mL, containing 50 ppm BHT) and then with anh diethyl ether (200 mL, containing 50 ppm BHT).
[0155] Obtained 3 H-G2-PEG2-FMOC-BTC 20K was dissolved in anh DCM (3.0 mL). NHS (90.1 mg) was added and the reaction mixture was stirred overnight at 4° C. Then anh IPA (40 mL, containing citric acid and BHT) was added. The suspension was cooled in an ice bath for 10 min, then the precipitate was filtered and washed with anh IPA (40 mL) containing BHT and with anh MTBE (100 mL) containing citric acid and BHT. The resulting product was dried under vacuum for about 4 hours. Yield 663 mg, 54% active NHS by HPLC of the glycine conjugate. 1 H-NMR (CD2Cl2): δ (ppm) 8.8, 8.7 (s, s, NH); 7.9-7.4 (m, Ar); 6.8 (bm, NH); 4.6 (m, CH); 4.3 (m, CH2); 3.6 (s, PEG backbone); 3.3 (s, OCH3); 2.8 (s, CH2); 2.5 (t, CH2); 2.3 (t, CH2); 2.0 (m, CH2). The specific activity was 7.0 Ci / mmol. Analysis by GPC showed that the 20K MW was 88% with both low and high MW fractions remaining.
[0156] The material was divided into three portions (220 mg each) for storage stability analysis at -80°C. The solid storage product (220 mg) was divided into aliquots of 40 mg each and stored at -80°C for later analysis. Another product (220 mg) was dissolved in anhydrous dichloromethane (4.4 mL) and stored at -80°C in 1 ml aliquots. The remaining product (220 mg) was dissolved in 2 mM HCl solution (2.2 mL, pH=2.55) and stored at -80°C in 0.5 ml aliquots. To observe the effect of radiolysis at different storage conditions, aliquots of the samples were analyzed for MW and substitution. The results at 14 days are summarized in Table 1.
[0157] [Table 1]
[0158] Example 5 Tritium exchange 3 Method for the synthesis of H-C2-PEG2-FMOC-NHS 20K Tritium exchange of mPEG-NH2 10kDa mPEG amine 10 kDa (2.0 g) was dissolved in 100 mM phosphate buffer pH 8.55 and palladium hydroxide on activated carbon (0.71 g, 20% Pd content (dry basis), water wet (50%) was added. The suspension was sparged with argon for 30 min and then frozen with liquid nitrogen. The frozen solution was then exposed to tritium gas, warmed to rt, and then blanketed with tritium for 3 h. The tritium gas was pumped out of the vessel and approximately 70 mL of DI water was added. The solution was filtered to remove the palladium catalyst. The water was distilled in vacuum at ambient temperature to remove the remaining tritium gas, and the residue was redissolved in 20-30 mL of DI water. The distillation and addition of water was repeated three times and the final solid was obtained in approximately 30 mL of DI water. Dissolved in DI water. NaCl (3 g) was added and the pH was adjusted to 9.5 with sodium hydroxide solution. The product was extracted with DCM (25 mL x 3; 5 mL x 1) and the extract was dried (Na2SO4). The solvent was then distilled under reduced pressure to give a solid. 3This resulted in 2.06 g of H-mPEG-NH2 10 kDa product. The specific activity for the product was 11.59 Ci / mmol. To lower the specific activity, the tritiated product was diluted with unlabeled mPEG amine 10 kDa. Thus, to the above tritiated sample, unlabeled mPEG amine 10 kDa (2.0 g) was added, and the resulting mixture was dissolved in DCM (6 mL). The diluted PEG amine was precipitated from the solution by the addition of IPA (150 mL, containing 100 ppm BHT) and diethyl ether (150 mL), then filtered. The precipitate was washed with diethyl ether (containing 100 ppm BHT) and dried under vacuum (approximately 30 min); yield 3.0 g, specific activity: 6.7 Ci / mmol.
[0159] 3 Preparation of H-C2-PEG2-FMOC-OH 20 kDa Labeled mPEG amine ( 3H-mPEG-NH210kDa) (3.0 g) and HOBt hydrate (46 mg, 0.28 mmol, 2.1 equiv) were dissolved in DCM (10 mL) and toluene (10 mL). The solvent was removed in vacuum at 25° C. and the residue was dried under a stream of nitrogen for about 20 min. In a separate flask, C2-FMOC-OH core (38.7 mg, 0.135 mmol, 1.0 equiv) was dissolved in anh DMF (2.2 mL). The solvent was then removed in vacuum at 50° C. The dried C2-FMOC-OH core material was dissolved in anh DMF and transferred to the mPEG amine-containing HOBt solution (2.2 mL dissolved, 1.0 mL transferred). DCC (86.0 mg, 0.42 mmol, 3.1 equiv) was added and the mixture was stirred at room temperature overnight. The crude product was isolated with IPA (120 mL), filtered, rinsed with diethyl ether (40 mL) and dried under vacuum. It was then dissolved in deionized water (120 mL) and the solution was further diluted with 180 mL of deionized water. The pH of the solution was adjusted to pH 9.7 with 1 M NaOH. Chromatographic removal of unreacted labeled mPEG-NH2 (10,000 Da) was carried out with POROS HS50 medium (40 mL) using water as eluent. The fractions containing neutral PEG were collected and further purified by filtration through DEAE Sepharose medium (30 mL). Diethylenetriaminepentaacetic acid (DTPA) solution and sodium chloride (170 g) were added and the pH was adjusted to 7.50 with 1 M NaOH. The product was extracted with DCM (total 120 ml). The extract was dried with sodium sulfate, filtered and IPA and diethyl ether were added. The precipitated product was dried under vacuum. Yield 1.53 g, specific activity: 11.6 Ci / mmol.
[0160] Activated Carbonate 3 Preparation of H-C2-PEG2-FMOC-NHS 20kDa. Labeled intermediates 3 H-C2-PEG2-FMOC-OH 20 kDa was converted to an active benzotriazolyl carbonate ( 3H-C2-PEG2-FMOC-BTC) carbonate and subsequent displacement with NHS. 3 H-C2-PEG2-FMOC-NHS 20kDa. 3 The yield of H-C2-PEG2-FMOC-NHS 20 kDa product was 1.24 g. 86% active NHS by HPLC of the glycine conjugate. 1 H-NMR (CD2Cl2; 300 MHz): δ (ppm) 8.0, 7.9 (d, d, Ar); 8.0 (s, Ar); 4.7 (d, CH2); 4.5 (t, CH); 4.3 (m, CH2); 3.6 (s, PEG backbone); 3.3 (s, -OCH3); 2.9 (s, CH2). Specific activity was 11.8 Ci / mmol. GFC: 3.1% high MW, 90.1% product, 6.8% LMW.
[0161] Example 6 Release rate of glycine conjugate For determination of the release rates of model drug conjugates, glycine conjugates were prepared from G2, Br-G2, and C2 PEG2-FMOC 20K NHS reagents using the procedure in Example 1. The results for the new structures are compared to previously described structures in Table 2.
[0162] Release data for G2-PEG2-FMOC-20K-glycine carbamate conjugate at 37° C. and pH 7.4: 15 days (one experiment) are consistent with previously reported values (Bentley et al., U.S. Pat. No. 8,252,275).
[0163] Release data for Br-G2-PEG2-FMOC-20K-glycine carbamate conjugate at 37° C. and pH 7.4: 2.3 days (one experiment).
[0164] Release data for C2-PEG2-FMOC-20K-glycine carbamate conjugate at 37° C. and pH 7.4: 1.0±0.06 days (duplicate experiments).
[0165] [Table 2]
[0166] Example 7 Detection of fulvene content in C2-PEG2-FMOC-NHS-20KDA Various lots of C2-PEG2-FMOC-NHS-20kDa were prepared generally as described in U.S. Patent No. 8,252,275. Various lots were analyzed for C2-PEG2-fulvene content by HPLC.
[0167] [Table 3]
[0168] Example 8 Reaction of C2-PEG2-fulvene with 3-mercaptopropionic acid followed by chromatographic purification to remove PEG-fulvene impurities [ka] In a stirred round-bottom flask, a 90:10 mixture of 2,7-C2-PEG2-FMOC-OH 20K and 2,7-C2-PEG2-fulvene 20K (25 mg), the latter prepared as described by Culbertson et al. (U.S. Pat. No. 8,905,235), was dissolved in a buffer solution of 50 mM HEPES containing 10 mM 3-mercaptopropionic acid (pH 6.8), and the reaction was allowed to proceed for 2 hours. The reaction mixture was then subjected to chromatographic removal of the resulting 2,7-C2-FMOC-acid using a DEAE Sepharose FF column. Reverse-phase HPLC analysis of the product (Waters 2695 HPLC system, C4 column, 10 mM K2HPO4-THF gradient, ambient temperature, flow rate of 0.5 mL / min, and UV detection (300 nm)) showed that the purified 2,7-C2-PEG2-FMOC-OH 20k contained only trace but detectable amounts of 2,7-C2-FMOC-fulvene 20K (approximately 0.2% by weight). The purified product did not contain 2,7-C2-FMOC-acid 20K.
[0169] This example illustrates yet another method for removing fulvene impurities from 9-hydroxymethylfluorene polymers. In this approach, the impurity fulvene is removed from 9-hydroxymethylfluorene polymers (i.e., any of the exemplary 9-hydroxymethylfluorene polymers described herein) by reaction with an exemplary bifunctional reactant, a thiol-carboxylic acid, in this example, 3-mercaptopropionic acid. The reactant contains a thiol group for selective reaction with the fulvene double bond (but not the 9-hydroxymethylfluorene polymer) and a carboxylic acid group to facilitate removal of the resulting 2,7-C2-FMOC-acid reaction product by chromatography, e.g., ion exchange chromatography. Suitable reactants for use in this method include, for example, C1-C10 mercaptoalkanoic acids, e.g., HS(CH2) 1~9C(O)OH. Although fulvene formation can occur during the formation of any of a number of FMOC species, such as 9-hydroxymethylfluorene polymers, as well as the formation of the corresponding esters and the like, this approach is not applicable to FMOC reagents that are sensitive to hydrolysis, such as BTC and NHS esters. According to a preferred embodiment of the present invention, for example, the following is provided: (Section 1) 1. A method for preparing a reactive polymeric reagent, comprising: (i) a water soluble 9-hydroxymethylfluorene polymer having the structure (I): [ka] Here, POLY a is a first water-soluble, non-peptidic polymer; POLY b is a second water-soluble, non-peptidic polymer; R e1 is the first electron changing group, if present; and R e2 is a second electron changing group, if present; L 1 is the first connected component; and L 2 is the second connected component; with dibenzotriazolyl carbonate in an aprotic organic solvent in the presence of a base under anhydrous conditions to provide a reaction mixture comprising a water soluble 9-methylbenzotriazolyl carbonate fluorene polymer having the structure: [ka] Here, POLY a , POLY b 、R e1 、R e2 、L 1 , and L 2 each have the meaning given in step (i), and (ii) recovering said water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer (II) by precipitation with an anhydrous solvent effective to promote precipitation of said water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer. (Section 2) Item 3. The method of item 1, wherein step (i) comprises reacting the water-soluble 9-hydroxymethylfluorene polymer of structure (I) with about 1 to about 30 equivalents of dibenzotriazolyl carbonate. (Section 3) 3. The method according to claim 1 or 2, wherein the base is an amine. (Section 4) 4. The method according to claim 3, wherein the base is a non-nucleophilic amine or a slightly nucleophilic amine. (Section 5) The base may be pyridine, 4-dimethylaminopyridine, N,N-diisopropylethylamine, 2,6-di-tert-butylpyridine, N-methylimidazole, N-methylmorpholine, 2,6-lutidine, 2,4,6-collidine, N,N,2,6-tetramethylpyridin-4-amine, N,N,N',N'-tetramethyl-1,6-hexamethyldiamine, or the like. 5. The method according to claim 3 or 4, wherein the amine is selected from the group consisting of N,N',N',N",N"-pentamethyldiethylenetriamine, hexamethylenetetramine, and insoluble polymer-bound forms of any of the foregoing. (Section 6) 6. The method according to any one of items 1 to 5, wherein step (i) comprises about 1 to about 30 equivalents of a base. (Section 7) 7. The method according to item 6, wherein step (i) comprises about 1 to about 10 equivalents of a base. (Section 8) The method according to any one of items 1 to 7, wherein step (i) is carried out under a dry and inert gas atmosphere. (Section 9) 9. The method according to any one of items 1 to 8, wherein step (i) is carried out with mechanical stirring. (Section 10) 10. The method according to any one of items 1 to 9, wherein the reaction step is carried out at a temperature in the range of about -20°C to about 35°C. (Section 11) 11. The method according to claim 10, wherein the reaction step is carried out at a temperature ranging from about -10°C to about 25°C. (Section 12) 11. The method according to claim 10, wherein the reaction step is carried out at a temperature ranging from about -5°C to about 10°C. (Section 13) 13. The method according to any one of the above items 1 to 12, wherein the water-soluble 9-hydroxymethylfluorene polymer in step (i) is dissolved in an anhydrous aprotic organic solvent. (Section 14) 14. The method according to any one of claims 1 to 13, wherein in step (ii), the anhydrous solvent effective to promote precipitation further comprises an acid. (Section 15) 15. The method of claim 14, wherein the anhydrous solvent effective to promote precipitation of the water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer comprises from about 0.0001 to about 0.5 mole percent acid. (Section 16) 16. The method according to item 14 or 15, wherein the acid is selected from the group consisting of acetic acid, phosphoric acid, citric acid, dibasic sodium phosphate, potassium hydrogen phosphate, sulfuric acid, meta-nitrobenzoic acid, trifluoroacetic acid, trichloroacetic acid, and p-toluenesulfonic acid. (Section 17) 17. The method according to claim 16, wherein the acid is selected from acetic acid, citric acid, and phosphoric acid. (Section 18) 18. The method according to claim 17, wherein the acid is phosphoric acid. (Section 19) Item 19. The method according to any one of items 1 to 18, further comprising dissolving the water-soluble 9-hydroxymethylfluorene polymer of structure (I) in the aprotic organic solvent to form a polymer solution before the reacting step, and drying the polymer solution by azeotropic distillation to obtain a polymer solution having a water content of less than 500 ppm. (Section 20) 20. The method of any one of claims 1 to 19, wherein the recovered water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer of step (ii) comprises less than 10 mole percent of water-soluble fulvene polymer. (Section 21) 21. The method according to any one of items 1 to 20, wherein the dibenzotriazolyl carbonate in step (i) is in a halogenated solvent. (Section 22) 22. The method according to claim 21, wherein the halogenated solvent is a chlorinated solvent which is dichloromethane or trichloroethylene. (Section 23) 21. The method according to any one of items 1 to 20, wherein the aprotic organic solvent in step (i) is selected from dimethylformamide, acetone, acetonitrile, dioxane, and tetrahydrofuran. (Section 24) 23. The method of any one of claims 14 to 22, wherein the recovering step comprises filtering the reaction mixture of step (i) to remove solids to provide a solution comprising the water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer, followed by adding an effective amount of anhydrous solvent to precipitate the water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer from the solution. (Section 25) 25. The method of any one of claims 1 to 24, further comprising isolating the recovered precipitated water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer by filtration. (Section 26) 26. The method according to any one of items 1 to 25, wherein the anhydrous solvent in step (ii) is miscible with the aprotic organic solvent in step (i) and is a solvent in which the water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer is substantially insoluble. (Section 27) 27. The method of any one of claims 1 to 26, wherein the anhydrous solvent effective to promote precipitation of the water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer is selected from diethyl ether, isopropyl alcohol, methyl-t-butyl ether, pentane, hexane, heptane, and mixtures of the foregoing. (Section 28) 28. The method according to any one of claims 1 to 27, further comprising washing the recovered water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer with an anhydrous solvent in which the water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer is substantially insoluble, the solvent comprising about 0.0001 to about 0.5 mole percent of an acid. (Section 29) (iii) The method according to any one of items 1 to 28, further comprising purifying the recovered water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer. (Section 30) 30. The method according to any one of items 1 to 29, comprising converting the recovered or purified water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer into a different reactive carbonate. (Section 31) 31. The method of claim 30, wherein the different reactive carbonate is a water-soluble 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymer. (Section 32) 32. The method according to claim 31, wherein the conversion reaction is carried out by reacting the recovered or purified water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer with N-hydroxysuccinimide in dichloromethane. (Section 33) The conversion reaction is carried out in the presence of dimethylaminopyridine. The method described. (Section 34) POLY a and POLY b 34. The method according to any one of items 1 to 33, wherein each of is polyethylene glycol. (Section 35) Each POLY a and POLY b 35. The method according to item 34, wherein the polyethylene glycol has a weight average molecular weight of about 120 daltons to about 100,000 daltons, about 250 daltons to about 60,000 daltons, or about 5,000 daltons to about 25,000 daltons. (Section 36) Each POLY a and POLY b Item 36. The method according to item 35 above, wherein the polyethylene glycol has a weight average molecular weight of about 250 daltons to about 60,000 daltons. (Section 37) The water soluble 9-hydroxymethylfluorene polymer of structure (I) has the following structure:
change
change
change
change
change
change
change
change
Claims
1. 1. A method for preparing a reactive polymeric reagent that minimizes the formation of a fulvene species, comprising: (i) a water soluble 9-hydroxymethylfluorene polymer having the structure (I): 【Chemistry 43】 Here, POLY a is a first water-soluble, non-peptidic polymer; POLY b is a second water-soluble, non-peptidic polymer; R e1 is the first electron changing group, if present; and R e2 is a second electron changing group, if present; L 1 is the first connected component; and L 2 is the second connected component; with dibenzotriazolyl carbonate in an aprotic organic solvent in the presence of a base under anhydrous conditions to provide a reaction mixture comprising a water soluble 9-methylbenzotriazolyl carbonate fluorene polymer having the structure: 【Chemistry 44】 Here, POLY a , POLY b , R e1 , R e2 , L 1 , and L 2 each have the meaning given in step (i), and (ii) recovering the water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer (II) by precipitation with an anhydrous solvent effective to promote precipitation of the water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer, wherein the recovered water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer comprises less than 15 mole percent water-soluble fulvene polymer. Including, wherein in step (ii), the anhydrous solvent effective to promote precipitation further comprises an acid. method.
2. 2. The method of claim 1, wherein step (i) comprises reacting said water-soluble 9-hydroxymethylfluorene polymer of structure (I) with 0.95 to 31.5 equivalents of a dibenzotriazolyl carbonate.
3. 3. The method of claim 1 or claim 2, wherein the base is an amine.
4. 4. The method of claim 3, wherein the base is a non-nucleophilic or slightly nucleophilic amine.
5. 5. The method of claim 3 or claim 4, wherein the base is selected from the group consisting of pyridine, 4-dimethylaminopyridine, N,N-diisopropylethylamine, 2,6-di-tert-butylpyridine, N-methylimidazole, N-methylmorpholine, 2,6-lutidine, 2,4,6-collidine, N,N,2,6-tetramethylpyridin-4-amine, N,N,N',N'-tetramethyl-1,6-hexamethyldiamine, N,N',N',N",N"-pentamethyldiethylenetriamine, hexamethylenetetramine, and insoluble polymer bound forms of any of the foregoing.
6. 6. The method of any one of claims 1 to 5, wherein step (i) comprises 0.95 to 31.5 equivalents of base.
7. 7. The method of claim 6, wherein step (i) comprises 0.95 to 10.5 equivalents of base.
8. The method according to any one of claims 1 to 7, wherein step (i) is carried out under a dry and inert gas atmosphere.
9. The method according to any one of claims 1 to 8, wherein step (i) is carried out with mechanical stirring.
10. The method of any one of claims 1 to 9, wherein the reacting step is carried out at a temperature in the range of -21°C to 36.75°C.
11. The method of claim 10, wherein the reacting step is carried out at a temperature in the range of -10.5°C to 26.25°C.
12. The method of claim 10, wherein the reacting step is carried out at a temperature in the range of -5.25°C to 10.5°C.
13. The method of any one of claims 1 to 12, wherein the water-soluble 9-hydroxymethylfluorene polymer of step (i) is dissolved in an anhydrous aprotic organic solvent.
14. 14. The method of any one of claims 1 to 13, wherein the anhydrous solvent effective to promote precipitation of the water soluble 9-methylbenzotriazolyl carbonate fluorene polymer comprises from 0.000095 to 0.525 mole percent acid.
15. 15. The method of any one of claims 1 to 14, wherein the acid is selected from the group consisting of acetic acid, phosphoric acid, citric acid, dibasic sodium phosphate, potassium hydrogen phosphate, sulfuric acid, meta-nitrobenzoic acid, trifluoroacetic acid, and trichloroacetic acid, p-toluenesulfonic acid.
16. 16. The method of claim 15, wherein the acid is selected from acetic acid, citric acid, and phosphoric acid.
17. 17. The method of claim 16, wherein the acid is phosphoric acid.
18. 18. The method of any one of claims 1 to 17, further comprising, prior to the reacting step, dissolving the water soluble 9-hydroxymethylfluorene polymer of structure (I) in the aprotic organic solvent to form a polymer solution and drying the polymer solution by azeotropic distillation to result in a polymer solution having a water content of less than 500 ppm.
19. 19. The method of any one of claims 1 to 18, wherein the recovered water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer of step (ii) comprises less than 10 mole percent water-soluble fulvene polymer.
20. 20. The method of any one of claims 1 to 19, wherein the dibenzotriazolyl carbonate in step (i) is in a halogenated solvent.
21. 21. The method of claim 20, wherein the halogenated solvent is a chlorinated solvent which is dichloromethane or trichloroethylene.
22. 20. The method according to any one of claims 1 to 19, wherein the aprotic organic solvent in step (i) is selected from dimethylformamide, acetone, acetonitrile, dioxane, and tetrahydrofuran.
23. 22. The method of any one of claims 1 to 21, wherein the recovering step comprises filtering the reaction mixture of step (i) to remove solids to provide a solution comprising the water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer, followed by adding an effective amount of anhydrous solvent to precipitate the water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer from the solution.
24. 24. The method of any one of claims 1 to 23, further comprising isolating the recovered precipitated water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer by filtration.
25. 25. The method of any one of claims 1 to 24, wherein the anhydrous solvent of step (ii) is a solvent that is miscible with the aprotic organic solvent of step (i) and in which the water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer is substantially insoluble.
26. 26. The method of any one of claims 1 to 25, wherein the anhydrous solvent effective to promote precipitation of the water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer is selected from diethyl ether, isopropyl alcohol, methyl-t-butyl ether, pentane, hexane, heptane, and mixtures of the foregoing.
27. 27. The method of any one of claims 1 to 26, further comprising washing the recovered water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer with an anhydrous solvent in which the water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer is substantially insoluble, the solvent comprising from 0.000095 to 0.525 mole percent acid.
28. 28. The method of any one of claims 1 to 27, further comprising (iii) purifying the recovered water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer.
29. 29. The method of any one of claims 1 to 28, comprising converting the recovered or purified water-soluble 9-methylbenzotriazolyl carbonate fluorene polymer to a different reactive carbonate.
30. 30. The method of claim 29, wherein the different reactive carbonate is a water soluble 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymer.
31. 31. The method of claim 30, wherein the conversion reaction is carried out by reacting the recovered or purified water-soluble 9-methylbenzotriazolylcarbonate fluorene polymer with N-hydroxysuccinimide in dichloromethane.
32. 32. The method of claim 31 , wherein the conversion reaction is carried out in the presence of dimethylaminopyridine.
33. POLY a and POLY b The method of any one of claims 1 to 32, wherein each of is polyethylene glycol.
34. Each POLY a and POLY b 34. The method of claim 33, wherein said polyethylene glycol has a weight average molecular weight of 114 daltons to 105,000 daltons, or 237.5 daltons to 63,000 daltons, or 4,750 daltons to 26,250 daltons.
35. Each POLY a and POLY b The method of claim 34, wherein is a polyethylene glycol having a weight average molecular weight of 237.5 Daltons to 63,000 Daltons.
36. The water soluble 9-hydroxymethylfluorene polymer of structure (I) has the following structure: 【Chemistry 45】 wherein each n independently ranges from 3 to 2273, or 4 to 1363, or 3 to 136, or 136 to 1818, or 113 to 568, or 227 to 568; said water soluble 9-methylbenzotriazolyl carbonate fluorene polymer of structure (II) has the following structure: 【Chemistry 46】 36. The method according to any one of claims 1 to 35.
37. 1. A method for preparing an N-hydroxylsuccinimidyl carbonate activated polymeric reagent that minimizes the formation of fulvene species, comprising: (i) a water soluble 9-hydroxymethylfluorene polymer having the structure: 【Chemistry 47】 Here, POLY a is a first water-soluble, non-peptidic polymer; POLY b is a second water-soluble, non-peptidic polymer; R e1 is the first electron changing group, if present; R e2 is a second electron changing group, if present; L 1 is the first connected component; L 2 is the second connected component; R e1 is a first electron changing group, which may be present or absent; and R e2 is a second electron changing group, which may or may not be present; with 0.95 to 21 equivalents of disuccinimidyl carbonate in an anhydrous aprotic organic solvent in the presence of a base to provide a reaction mixture comprising a water soluble 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymer having the following structure: 【Chemistry 48】 Here, POLY a , POLY b , R e1 , R e2 , L 1 , and L 2 each have the meaning described in step (i); and (ii) recovering said water-soluble 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymer of structure (III) from said reaction mixture, wherein said recovered water-soluble 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymer comprises less than 15 mole percent water-soluble fulvene polymer. Including, wherein prior to the reacting step (i), the water-soluble 9-hydroxymethylfluorene polymer is dissolved in the anhydrous aprotic organic solvent to provide a polymer solution, and subsequently, the polymer solution is dried to remove any water present, resulting in a dry polymer solution having a water content of less than 500 ppm; method.
38. 38. The method of claim 37, wherein the drying is repeated until a dry polymer solution having a water content of less than 200 ppm or less than 100 ppm is reached.
39. 39. The method of claim 37 or 38, wherein the drying step comprises azeotropically distilling the polymer solution.
40. The method according to any one of claims 37 to 39, wherein the drying is repeated until the water content of the polymer solution remains constant.
41. The method of any one of claims 37 to 40, wherein the base is a non-nucleophilic or slightly nucleophilic amine.
42. 42. The method of claim 41, wherein the base is selected from the group consisting of pyridine, 4-dimethylaminopyridine, N,N-diisopropylethylamine, 2,6-di-tert-butylpyridine, N-methylimidazole, N-methylmorpholine, 2,6-lutidine, 2,4,6-collidine, N,N,2,6-tetramethylpyridin-4-amine, N,N,N',N'-tetramethyl-1,6-hexamethyldiamine, N,N',N',N",N"-pentamethyldiethylenetriamine, hexamethylenetetramine, and insoluble polymer bound forms of any of the foregoing.
43. 43. The method of any one of claims 37 to 42, wherein step (i) comprises 0.95 to 15.75 equivalents of base.
44. 44. The method of claim 43, wherein step (i) comprises 2.85 to 10.5 equivalents of base.
45. A method according to any one of claims 37 to 44, wherein step (i) is carried out under a dry and inert atmosphere.
46. 46. The method of any one of claims 37 to 45, wherein the reacting step (i) comprises adding the disuccinimidyl carbonate to a solution of the water-soluble 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymer in the anhydrous aprotic organic solvent while maintaining the temperature between 0 and 31.5°C.
47. 47. The method of claim 46, wherein the reacting step (i) further comprises adjusting the temperature of the reaction mixture to between 7.125 and 18.9° C. after the adding step, followed by adding a base.
48. 48. The method of any one of claims 37 to 47, wherein step (i) is carried out with mixing.
49. 49. The method of claim 48, wherein during said mixing, the temperature of the reaction mixture is maintained in a range between 2.85°C and 22.05°C.
50. 50. The method of any one of claims 37 to 49, further comprising adding an acid to the reaction mixture of step (i) prior to the recovering step in an amount effective to neutralize the base.
51. 51. The method of claim 50, wherein the acid is selected from the group consisting of acetic acid, phosphoric acid, citric acid, dibasic sodium phosphate, potassium hydrogen phosphate, sulfuric acid, meta-nitrobenzoic acid, trifluoroacetic acid, p-toluenesulfonic acid, and trichloroacetic acid.
52. 52. The method of claim 51 , wherein the acid is selected from acetic acid, citric acid, and phosphoric acid.
53. 53. The method of any one of claims 37-52, wherein the recovered water-soluble 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymer comprises 15 mole percent or less of water-soluble fulvene polymer.
54. 54. The method of any one of claims 37-53, wherein the recovering step (ii) comprises (ii-a) filtering the reaction mixture to remove solids to provide a solution, followed by (ii-b) precipitating the water-soluble 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymer from the solution.
55. 55. The method of claim 54, wherein said precipitating step comprises the addition of an anhydrous precipitating solvent in which said water soluble 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymer is substantially insoluble.
56. 56. The method of claim 55, wherein the precipitating solvent is at a temperature above its freezing point and below room temperature.
57. 57. A method according to claim 55 or claim 56, wherein the precipitating solvent contains a small amount of acid sufficient to essentially neutralise any remaining base.
58. 58. The method of any one of claims 55 to 57, wherein the precipitating solvent is selected from diethyl ether, isopropyl alcohol, methyl t-butyl ether, ethyl acetate, pentane, hexane, heptane, and mixtures of the foregoing.
59. 59. The method of any one of claims 37 to 58, further comprising washing the recovered water-soluble 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymer with an acidified precipitating solvent.
60. 60. The method of any one of claims 37-59, further comprising (iv) purifying the recovered water-soluble 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymer.
61. 61. The method of claim 60, further comprising detecting a water soluble fulvene polymer in the recovered water soluble 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymer, and wherein said purifying step (iv) comprises dissolving the recovered water soluble 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymer in a solvent to provide a solution, passing the solution through a thiol-containing resin to remove any water soluble fulvene polymer, thereby providing a purified solution, and removing the solvent from the purified solution to recover the purified water soluble 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymer.
62. The water soluble 9-hydroxymethylfluorene polymer of step (i) has the following structure: 【Chemistry 49】 62. The method of any one of claims 1 to 61, wherein each n is independently 3 to 2273, or 4 to 1363, or 3 to 136, or 136 to 1818, or 113 to 568, or 227 to 568.
63. The water soluble 9-hydroxymethylfluorene polymer of step (i) has the following structure: 【Chemistry 50】 62. The method of any one of claims 1 to 61, wherein each n is independently 3 to 2273, or 4 to 1363, or 3 to 136, or 136 to 1818, or 113 to 568, or 227 to 568.
64. The water soluble 9-hydroxymethylfluorene polymer of step (i) has the following structure: 【Chemistry 51】 The method of any one of claims 1 to 61, wherein each n is independently 3 to 227.
65. R e1 and / or R e2 are each independently halo, nitro, lower alkyl, lower alkoxy, trifluoromethyl, and -SO 3 65. The method of claim 63 or 64, wherein said alkyl group is selected from H.
66. L 1 and L 2 The method of any one of claims 63 to 65, wherein each independently has a length of 1 to 25 atoms.
67. R e1 and R e2 and wherein both are located on the same aromatic ring.
68. R e1 and R e2 are located on different aromatic rings.
69. L 1 and L 2 Each independently represents -(CH 2 ) 1~6 C(O)NH- and -NH-C(O), NH-C(O)-(CH 2 ) 1~6 69. The method of any one of claims 62 to 68, wherein the alkyl group is selected from the group consisting of C(O)NH-.
70. L 1 and L 2 Each independently represents -(CH 2 )C(O)NH-,-(CH 2 ) 3 C(O)NH-, -NH-C(O), and NH-C(O)-(CH 2 ) 3 70. The method of claim 69, wherein said alkyl group is selected from the group consisting of C(O)NH-.
71. 71. The method of any one of claims 62-70, wherein the weight average molecular weight of each polyethylene glycol in structure (I) is the same (e.g., each "n" is the same).
72. 72. The method of claim 71, wherein each polyethylene glycol in structure (I) has a weight average molecular weight ranging from 114 Daltons to 6,300 Daltons.
73. 72. The method of claim 71, wherein each polyethylene glycol in structure (I) has a weight average molecular weight ranging from 5,700 Daltons to 84,000 Daltons.
74. 72. The method of claim 71, wherein each polyethylene glycol in structure (I) has a weight average molecular weight selected from the group consisting of about 5,000 daltons, 7500 daltons, 10,000 daltons, 15,000 daltons, 20,000 daltons, 30,000 daltons, and 40,000 daltons, where "about" means within ±5% of the specified quantity.
75. 75. The method of any one of claims 62-74, wherein in structures (I) and (II), L1 is attached to fluorene carbon-5 and L2 is attached to fluorene carbon-2.
76. 75. The method of any one of claims 62-74, wherein in structures (I) and (II), L1 is attached to fluorene carbon-7 and L2 is attached to fluorene carbon-2.
77. The method of any one of claims 62 to 74, wherein structure (I) is selected from the group consisting of: 【Chemistry 52】
78. 37. The method of any one of claims 1 to 36, further comprising reacting the recovered or purified water soluble 9-methylbenzotriazolyl carbonate fluorene polymer or other reactive carbonate with an amine-containing biologically active agent.
79. 78. The method of any one of claims 37-77, further comprising reacting the recovered or purified water soluble 9-methyl N-hydroxysuccinimidyl carbonate fluorene polymer with an amine-containing biologically active agent.
Citation Information
Patent Citations
Method for the preparation of 1-benzotriazolyl carbonate of poly(ethylene glycol)
JP2003518151A
Methods of preparing polymeric reagents and compositions of polymeric reagents
JP2009503201A
glp-1 polymer complex
JP2009519961A
Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
US8252275B2
